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Abstract 
 
Circadian rhythms are important for organisms to anticipate predictable environmental 
changes. Evidence indicates that the oscillation of murine blood numbers is closely 
related to the lighting schedule. However, the dynamics and the mechanisms of the 
migration of leukocyte subsets over 24 hours are unknown. Here, we could show that 
that numbers of circulating leucocyte subsets exhibit circadian rhythms in murine 
blood, which was regulated by rhythmic homing, with a co-contribution of both 
microenvironmental and leukocyte-autonomous oscillations. We identified leukocyte 
and vascular bed specific surface expression oscillations of adhesion molecules and 
chemokine receptors over 24 hours. To test the relevance of these oscillations, 
functional blocking experiments using antibodies or functional blockers directed 
against pro-migratory molecules were performed. Our data indicate the adhesion 
molecules CD11a, CD49d and L-selectin and the chemokine receptor CXCR4 on the 
leukocyte side, as well as VCAM-1 and ICAM-1 on the endothelial side to be important 
in the rhythmic recruitment process of leukocyte subsets. A stronger blocking effect 
targeting these molecules was found at night for leukocyte subsets. In the homing 
experiments, we found donor leukocytes preferentially migrated to organs at night, and 
that the recruitment process of different leukocyte subsets to various organs could be 
blocked by distinct inhibitors. We exposed the role of circadian genes in the rhythmic 
recruitment process using B-cell and myeloid-cell-specific knockouts of the circadian 
gene Bmal1, which demonstrated altered expression levels of specific oscillatory 
molecules and leukocyte numbers in tissues, suggesting that rhythmicity in these 
factors may be directly regulated by the circadian clock. Furthermore, we detected 
inverse oscillation patterns of human blood cell numbers compared to murine cells as 
well as of the expression levels of CXCR4 on leukocyte subsets. Together, our data 
demonstrate that circadian genes control a rhythmic leukocyte- and tissue-specific 
molecular signature in the expression of pro-migratory factors, which allows for the 
recruitment of select leukocyte subsets at distinct times. 
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1. Introduction 
 
1.1. The Circadian system 
 
1.1.1. Circadian rhythms 
 
Circadian rhythms exhibit a period length of about 24 hours. The term circadian comes 
from the Latin circa, meaning "around", and diem meaning "day". Organisms exposed 
to daily environmental cycles display rhythms in physiology, metabolism and behavior, 
which help them anticipate predictable environmental changes.  
The simplest organisms known to exhibit circadian rhythms are cyanobacteria (Bhadra 
et al. 2017). Cyanobacteria can generate nutrients by photosynthesis and nitrogen 
fixation. Because the by-product of photosynthesis, oxygen, can inhibit the enzymes 
involved in nitrogen fixation, the two processes need to be separated either spatially 
or temporally. Since unicellular cyanobacteria do not have means for spatial separation, 
they therefore temporally separate these two processes, with photosynthesis taking 
place during the day, while nitrogen fixation occurs during night. Interestingly, when 
shifted to constant light, this rhythmicity is still maintained (Bhadra et al. 2017; Golden 
et al. 1997).  
This example shows an essential characteristic of a bona fide circadian rhythm, namely 
that these rhythms must oscillate in a constant environment, independent from external 
factors, such as food intake and light. Moreover, circadian rhythms are driven by 
endogenous cell-autonomous clocks, but can be entrained to external Zeitgebers (time 
giver, e.g. light and food). Classical factors exhibiting circadian rhythms in mammals 
are core body temperature oscillations as well as plasma cortisol or melatonin levels. 
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1.1.2. The molecular clock machinery 
 
The molecular clock consists of autoregulatory transcription-translation feedback loops, 
which have been largely discovered in studies using drosophila and mice. The core 
clock genes are Bmal1 (brain and muscle Arntl-like protein 1) and Clock (circadian 
locomotor output cycles kaput), which are responsible for all circadian output (Hardin 
and Panda 2013).  
The BMAL1 protein heterodimerizes with CLOCK, and together they bind to promoter 
sequences called Enhancer Boxes (E-Box) to activate transcription of genes 
(Darlington et al. 1998). This includes their own repressors, which are three PER 
proteins (period circadian protein 1-3), and two CRY flavoproteins (cryptochrome 1 and 
2). These proteins form PER-CRY heterodimer complexes in the cytoplasm and move 
into the nucleus to interfere with CLOCK-BMAL1 complex activities (Jin et al. 1999; 
Griffin, Staknis, and Weitz 1999; Gekakis et al. 1998). When enough of the PER/CRY 
complexes are degraded by the proteasome, BMAL1/CLOCK expression increases 
and the cycle starts new (Golombek and Rosenstein 2010). 
An accessory loop in mammals is generated by the nuclear hormone receptors, RAR-
orphan receptor α/β/γ (Ror α/β/γ), and REV-ERBα/REV-ERBβ proteins (encoded by 
Nr1d1 and Nr1d2), which bind Rev-Erb/ROR response elements (RREs) to active and 
inhibit Bmal1 transcription, respectively (Preitner et al. 2002; Sato et al. 2004).  
One cycle of the core feedback loop thus includes activator binding to E-boxes, the 
transcription of clock genes and clock-controlled genes, RNA processing and their 
cytoplasmic transport, protein synthesis, dimerization and nuclear localization of the 
repressors, transcriptional repression, and degradation of repressors (Hardin 2011).  
A key event regulating circadian period is protein phosphorylation. Protein kinases 
casein kinase I epsilon (CKIε) and delta (CKIδ) (encoded by Csnk1d and Csnk1e, 
respectively) regulate PER1/2/3 and CRY1/2 protein degradation and nuclear 
localization through phosphorylation (Vielhaber et al. 2000; Maywood et al. 2014; 
Etchegaray et al. 2009). CKIε or CKIδ can also regulate BMAL1 phosphorylation and 
thus mediate CLOCK-BMAL1 dependent transcription (Eide et al. 2002). Therefore, 
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mutations in both Csnk1d and Csnk1e present profound changes in circadian cycle 
length.  
Moreover, various epigenetic mechanisms that modify the architecture of chromatin 
have also been implicated in regulating CLOCK-BMAL1 transcriptional output. 
Circadian transcription of CLOCK-BMAL1 target genes correlates with circadian 
changes in histone acetylation (Papazyan, Zhang, and Lazar 2016). Four core histones 
(H2A, H2B, H3, and H4) wrap DNA and form the histone octamer of nucleosome. The 
histone variant H2A.Z can be deposited at both promoters and intergenic regulatory 
regions of CLOCK-binding sites to open DNA/nucleosome structure and provide a 
binding platform for transcription factors to regulate gene expression (Subramanian, 
Fields, and Boyer 2015). The CLOCK protein has been found to be a histone 
acetyltransferase (Doi, Hirayama, and Sassone-Corsi 2006), indicating the critical 
importance of histone acetylation in circadian gene regulation. 
 
Figure 1.1 The molecular clock 
The core component BMAL1 and CLOCK form a heterodimeric transcription factor complex 
which binds to E-box motifs of clock-controlled genes. This drives the negative feedback 
loop of PER-CRY heterodimer complexes to inhibit CLOCK/BMAL1-induced gene 
expression. Phosphorylation of PER by CKIε/δ will cause its degradation by the proteasome.  
A second feedback loop involves REV-ERBα and REV-ERBβ proteins. They compete with 
ROR proteins to inhibit Bmal1 transcription via Rev-Erb/ROR response (RORE) elements 
(Golombek and Rosenstein 2010) . 
 
Also, non-transcriptional/translation events are sufficient to sustain cellular circadian 
rhythms. In the cyanobacterial clock system, circadian rhythms can be generated 
without transcription-translation feedback loop (Nakajima et al. 2005). This is also the 
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case for anuclear red blood cells, where the redox status drives circadian rhythms 
(O'Neill and Reddy 2011). Therefore, an organism or cell does not necessarily need 
the above described clock genes to exhibit functional circadian rhythms.  
 
 
1.1.3. The central clock and synchronization of the 
organism 
 
Although virtually every cell has its autonomous clock, these clocks need to be 
synchronized in order to be in phase coherence with the exogenous environment, as 
well as with tissues and organs within the organism. This is achieved by the central 
clock, which is located within the superchiasmatic nuclei (SCN), consisting of about 
20000 highly interconnected neurons. The SCN is located above the optic chiasm in 
the anterior hypothalamus. It links the organism to environmental changes via the eyes. 
The primary environmental cue of circadian rhythms is therefore light. This timing 
information is conveyed by non-image forming, photosensitive retinal ganglion cells 
(Lucas et al. 1999), and transmitted to the central clock via the retinohypothalamic tract. 
The prominent role of SCN was confirmed due to the loss of activity rhythms after 
ablation of the SCN and restoration of circadian activity rhythms by SCN tissue 
transplantation (Lehman et al. 1987) 
Output projection from the SCN can target many different brain regions, and these 
output pathways are responsible for the proper timing of hormone release, behavior 
states and body temperature fluctuations. For example, the supraventricular zone 
(sPVz) projections to the medial preoptic region (MPO) are involved in the control of 
circadian rhythms in body temperature. The dorsomedial nucleus of the hypothalamus 
(DMH), which receives input from SCN both directly and via the subparaventricular 
zone (sPVz), controls sleep-wake cycle and daily hormone secretion via the 
paraventricular nucleus (PVN) of the hypothalamus (Takahashi et al. 2008).  
Central clock signals are transmitted to peripheral tissues directly or indirectly via 
neuronal or humoral pathways. Two hormones that show strong circadian rhythms are 
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melatonin and glucocorticoids (cortisol in humans and corticosterone in mice). In 
humans, plasma levels of melatonin start to rise about two hours before the habitual 
bedtime and remain at a high level during night-time (Benarroch 2008).The primary 
site of melatonin synthesis is the pineal gland. Increased activity of the SCN during the 
light phase can reduce sympathetic output to the pineal gland via the SCG (superior 
cervical ganglion), and inhibit melatonin secretion (Maronde and Stehle 2007). 
Melatonin has a variety of function, including sleep induction, blood pressure regulation 
and enhancement of immune responses (Benarroch 2008). However, the most 
commonly used mouse strain, the C57BL/6 line, is a natural hypomorph for melatonin 
but still exhibits strong circadian rhythms, indicating a non-critical role for melatonin in 
mediating rhythmicity in the mouse (Tosini et al. 2014).  
Glucocorticoids regulate a broad spectrum of physiologic functions for life. Both in 
humans and rodents, glucocorticoids peak around the onset of the activity phase, in 
the early morning in diurnal humans and in the early night in nocturnal animals 
(Dickmeis 2009). Diurnal glucocorticoid secretion is under control of the SCN, the 
hypothalamic-pituitary adrenal (HPA) axis as well as an adrenal gland intrinsic 
oscillator (Chung et al. 2017). Release of adrenocoticotropic hormone (ACTH) is 
regulated by the SCN and output through the hypothalamus, which causes the 
production of glucocorticoids in a circadian manner. Rhythmic secretion of 
glucocorticoids can entrain signals for peripheral oscillators in target tissues, such as 
lung, liver, heart and skeletal muscles (Almon et al. 2008; Balsalobre et al. 2000; Gibbs 
et al. 2014).  
Another way of transferring a synchronizing signal to peripheral tissues is via cyclical 
release of norepinephrine locally from nerve varicosities by sympathetic nerves 
(Scheiermann, Kunisaki, and Frenette 2013). Light exposure can induce changes in 
the liver mRNA levels of clock genes and output genes. However, this change was 
abolished by removing liver innervation, indicating autonomic input to be an essential 
gateway for the transmission of light information from the SCN (Cailotto et al. 2009). 
Neural inputs mediated by β2-adrenergic receptors (β2ARs) generate the diurnal 
variation of lymphocyte egress from lymph node, with less lymphocyte recirculating 
into blood at night, which contributes to more efficient adaptive immune response this 
time point (Suzuki et al. 2016). Signals from the sympathetic nervous system delivered 
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by adrenergic nerves can also regulate rhythmic recruitment of leukocytes to skeletal 
muscles and bone marrow (Scheiermann et al. 2012). In addition, noradrenaline 
secreted by the sympathetic nervous system in a circadian manner regulates the 
rhythmic release of hematopoietic stem cells (HSCs) from the bone marrow and 
expression of Cxcl12 in this tissue (Mendez-Ferrer et al. 2008). These examples 
demonstrate that the sympathetic nervous system serves as an important way to 
transfer synchronizing information to peripheral tissues. 
21 
 
 
Figure 1.2 Peripheral clock entrainment pathways 
The SCN central pacemaker establishes phase coherence in the periphery via multiple 
routes. Via neutral projection into other parts of the brain, the SCN can influence body 
temperature and rest/behavioral activity. Another way to transmit signals directly to 
peripheral tissues is via the sympathetic nervous system and humoral signals (Dibner, 
Schibler, and Albrecht 2010). 
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1.1.4. The peripheral clock 
 
The circadian clock is ticking not only in central neurons but also in virtually all 
peripheral tissues (Maury, Ramsey, and Bass 2010). Peripheral clocks are cell 
autonomous oscillators that can operate independently from the SCN. In vitro cultured 
tissues from liver, lung, kidney and spleen still exhibit strong circadian oscillations in 
gene expression, demonstrating that non-SCN peripheral cells also contain their own 
endogenous circadian oscillators (Keller et al. 2009; Sumova et al. 2006).  In addition, 
a liver-specific Bmal1 deficient mouse strain was shown to lose rhythmic expression of 
hepatic glucose regulatory genes and exhibits hypoglycemia (Lamia, Storch, and Weitz 
2008). 
Although the peripheral clock is self-sustained, it still needs the synchronizing 
information from the SCN. In SCN-lesioned mice, the peripheral tissues continue to 
oscillate, but their phases are no longer coordinated so that the result is behaviorally 
arrhythmic animals (Tahara et al. 2012). Furthermore, in ‘jet lag’ experiments, where 
light cycles were advanced or delayed by 6 hours, the resynchronization of peripheral 
oscillators needs over a week, while the SCN can reset rapidly to a time shift 
(Yamazaki et al. 2000). Taken together, the peripheral clock is synchronized by the 
SCN, but can oscillate in a self-sustained manner. 
 
1.2. Leukocyte migration 
 
1.2.1. Blood leukocyte numbers oscillate over 24 
hours 
 
Blood flow helps distribute leukocytes to where and when they are needed in the body 
to drive immune responses and facilitate tissue repair. A circadian variation in total 
leukocyte counts has been known in various species including humans and mice. In 
murine blood, total leukocyte numbers fluctuate during 24 hours with a peak during the 
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rest phase and a trough during the active phase (Ohkura et al. 2007). Daily oscillations 
in peripheral blood have also been described in leukocyte subsets, such as total 
lymphocytes, neutrophils (Oishi et al. 2006), Ly6Ghi monocytes (Nguyen et al. 2013) 
and T cells (Druzd et al. 2017). In humans, blood cells oscillate in a similar way but at 
inverse times, since humans are not nocturnal (Born et al. 1997). However, using a 
humanized mouse model, in which both human and mouse leukocytes circulate in a 
murine host, it was shown that they exhibit opposite oscillations. Leukocytes exhibited 
opposite number oscillations due to differential cellular levels of reactive oxygen spices 
in mouse and human cells regulated through p38 mitogen-activated protein kinase 
pathway (Zhao et al. 2017). This indicates that – at least in this model – leukocytes are 
responsible for the oscillations in a cell-autonomous manner.  
 
1.2.2. Circulating blood cell numbers 
 
The underlying mechanisms of circadian changes in circulating blood cells are 
composed of multiple factors, such as distribution of cells between the circulation and 
a marginal cell compartment in tissues, influx of leukocytes from storage sites, and 
efflux of blood cells into lymphoid, hematopoietic or other tissues (Scheiermann, 
Frenette, and Hidalgo 2015; Ohkura et al. 2007).  
The efflux of blood leukocyte into tissues could be one of the major reasons of the 
dramatic leukocyte numbers drop at the onset of activity phase. Leukocytes recruited 
from blood to tissues in steady-state conditions serve four main purposes, definitive 
elimination, recirculation, tissue repair and replenishment (Scheiermann, Frenette, and 
Hidalgo 2015). Regardless of the purpose of the recruited cell, the basic mechanisms 
that lead leukocytes to migrate into tissues are a series of interactions with the 
endothelium, which was summarized as the leukocyte adhesion cascade as discussed 
below. 
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1.2.3. Leukocyte adhesion cascade 
 
1.2.3.1. Leukocyte migration in venules 
 
Most of the leukocyte migration process to tissues occurs at the sites of postcapillary 
venules. This process is organized into well recognized steps, including rolling, 
adhesion, crawling and transmigration. Studies have expanded on this process to 
include more features such as intraluminal crawling, paracellular and transcellular 
migration, as well as migration through the basement membrane (Ley et al. 2007; 
Kolaczkowska and Kubes 2013).  
Leukocyte emigration from the blood stream is initiated by the interaction of leukocytes 
with endothelial cells that coat the vessels and thus provide first interactions points. 
The cell-surface proteins selectins can interact with glycoproteins and other 
glycosylated ligands to produce weak binding between leukocytes and endothelial cells. 
Selectins include L-selectin, P-selectin and E-selectin. Most leukocytes express L-
selectin, whereas E-selectin and P-selectin are mostly expressed on endothelial cells, 
particularly after being induced by inflammatory cytokines (Ley et al. 2007; Hidalgo et 
al. 2007). All three selectins can interact with P-selectin glycoprotein ligand 1 (PSGL1), 
which is expressed on almost all leukocytes and also certain endothelial cells, such as 
venules of murine mesenteric lymph node and small intestine (Rivera-Nieves et al. 
2006). In addition to PSGL-1, E-selectin also binds to glycosylated CD44 (Dimitroff et 
al. 2001) and E-selectin ligand 1 (ESL1) to promote rolling (Hidalgo et al. 2007).  
Through the process of rolling, leukocytes slow down and come in close contact with 
endothelial cells and thus are exposed to chemokines immobilized on the endothelial 
cell surface. Chemokine binding to G-protein coupled receptors expressed by 
migrating leukocytes induce conformational changes of leukocyte integrins, from a low-
affinity ‘bent’ structure to an intermediate and ‘upright’ high affinity conformation, which 
in turn mediates firm adhesion to the endothelium (Campbell and Humphries 2011). 
The most important integrins are the two β2 integrins, leukocyte function-associated 
antigen-1 (LFA-1, αLβ2, CD11a/CD18), which is expressed by all leukocytes, and 
25 
 
Macrophage-1 antigen (Mac-1, αMβ2, CD11b/CD18), which is expressed 
predominantly by myeloid cells, and the two α4 integrins, very late antigen 4 (VLA-4, 
α4β1, CD49d/CD29), which is expressed by all leukocytes, and α4β7, which is mainly 
expressed on T cells for gut-specific homing (Marelli-Berg et al. 2008; Vestweber 2015; 
Kim 2005; Henderson et al. 2001; Fleming et al. 2003; Gan et al. 2012; Lim et al. 2000). 
The activated integrins bind to members of the endothelial immunoglobulin 
superfamily.  α4β7 binds to mucosal adhesion-cell adhesion molecule 1(MAdCAM-1). 
VLA-4 binds to vascular-cell adhesion molecule 1 (VCAM-1), and β2 integrins bind 
intracellular adhesion molecule 1 (ICAM-1), and intracellular adhesion molecule 2 
(ICAM-2) (Vestweber 2015).  
The final stage in the process of leukocyte emigration into extravascular tissue involves 
crossing the vascular wall and its associated perivascular basement membrane. Most 
leukocytes cross the endothelial barrier through endothelial cell junctions, which is 
called the paracellular route. A minor pathway where leukocytes migrate through the 
body of endothelial cells is called the transendothelial pathway, which still often occurs 
close to the cell junction (Vestweber 2015). A lot of molecules are involved in leukocyte 
diapedesis, such as ICAM-1, ICAM-2; junctional adhesion molecule (JAM) A, B and C; 
platelet endothelial cell adhesion molecule 1 (PECAM-1); CD99; and endothelial cell-
selective adhesion molecule (ESAM) (Marelli-Berg et al. 2008).  
 
Figure 1.3 Adhesion cascade of leukocyte 
Leukocyte migration from blood into tissues through selectin-mediated rolling, chemokine-
triggered activation and integrin-dependent arrest, and transendothelial migration 
(Vestweber 2015).  
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1.2.4. Recruitment of leukocytes 
 
With the discovery of the adhesion cascade, more and more evidence suggests that a 
specific expression pattern of pro-migratory molecules in tissues and leukocytes is of 
key importance for specific leukocyte subsets migrating into distinct tissues.  
 
1.2.4.1. Leukocyte migration to the lung 
 
The lung vasculature is composed of extremely thin capillaries which have a 
continuous and non-fenestrated endothelium to facilitate gas exchange. The capillaries 
form a complex interconnecting network of short vessels to build the alveolar-capillary 
membrane and perform barrier function (Leick et al. 2014; Lahm et al. 2007). Previous 
studies found leukocyte recruitment to occur predominantly at the level of capillaries, 
rather than postcapillary venules, which is in stark contrast to other tissues (Looney 
and Bhattacharya 2014; Wang, Doerschuk, and Mizgerd 2004).    
The structural features of the lung capillaries (2-15 µm in diameter) make it difficult for 
neutrophils (6-8 µm in diameter) and even red blood cells (5-6 µm in diameter) to pass 
through. Neutrophils (and other cell types) are retained intravascularly in the lung and 
are temporarily sequestered from the circulation blood. Therefore, the lung serves as 
a reservoir of leukocytes, which is referred to as marginated pool. The marginated pool 
helps keep a dynamic equilibrium with the circulating pools of leukocytes (Looney and 
Bhattacharya 2014; Kuebler and Goetz 2002). In order to pass through the lung 
capillary network, leukocytes have to perform a morphology change from spherical 
shapes in arterioles to elongated shapes in the capillary. 
Spatial constrains of the lung capillary rather than selectin-mediated rolling seems to 
dominate neutrophil retention in lung capillaries. Neither P-selectin nor E-selectin is 
constitutively expressed by the pulmonary capillary endothelium, and L-selectin played 
no role in neutrophil accumulation and margination in normal lungs (Doyle et al. 1997). 
However, blocking CD11b/CD18 and ICAM-1 interactions with antibodies largely 
prevented neutrophil sequestration and emigration into the alveolar space induced by 
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inflammatory stimuli (Moreland et al. 2002). In addition, CD11b/CD18-independent 
adhesion was shown not to be mediated by members of the selectin family, VLA-4, or 
PECAM-1 (Wang, Doerschuk, and Mizgerd 2004).  
 
Figure 1.4 Difference in neutrophil migration in pulmonary circulation and in systemic and 
bronchial circulation 
Neutrophils migration in systemic and bronchial circulation is selectin and CD18-dependent, 
while pulmonary circulation in steady state is selectin and CD18 independent unless induced 
by inflammatory stimuli (Wagner and Roth 2000).  
 
By in vivo imaging with LysM-GFP transgenic mice, monocytes were found moving in 
a jerky intermittent pattern in alveolar capillaries and rarely arrested inside vessels or 
entering the tissue in the absence of inflammation. But monocytes were found rolling 
and occasionally entering the tissues under inflammatory conditions (Kreisel et al. 
2010). In vivo homing assays also found circulating lymphocytes to be retarded for a 
certain time within the lung. Deficiency in the ICAM-1 pathway resulted in a decreased 
trapping of lymphocytes in the lung. However, blocking of ICAM-2 did not result in 
reduced lymphocyte numbers (Lehmann et al. 2003). 
To conclude, neutrophils remain in the lung mostly as a marginated pool due to the 
unique morphology of lung capillaries, while in some inflammatory conditions, 
adhesion molecules were shown to be involved in neutrophil sequestration in the lung. 
Monocytes are rarely found in the lung without inflammatory stimuli. Lymphocyte 
migration into the lung is ICAM-1 dependent. 
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1.2.4.2. Leukocyte migration in liver 
 
The liver has a dual blood supply due to its unique vascular architecture, consisting of 
the portal vein and the hepatic artery. Therefore, the microvasculature receives both 
arterial and venous blood that drains into post sinusoidal central veins. The hepatic 
capillaries are morphologically unique. They are lined with fenestrated endothelium 
and are separated from hepatocytes by a discontinuous basement membrane and a 
perisinusoidal space called ‘Space of Disse’. Microvilli of the hepatocytes can extend 
into this space, and Kupffer cells, which are also known as stellate macrophages in the 
liver, are located in the space (Leick et al. 2014).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
The majority of leukocyte adhesion in the liver occurs within sinusoids (80%), while 
only 20% of adhesion occurs in post-sinusoidal venules in response to a chemotactic 
stimulus (Wong et al. 1997). Recruitment of leukocytes in the post-sinusoidal venules 
of the liver follows a similar paradigm to the multi-step cascade with a rolling step 
before adhesion. But unlike in post-capillary venules, the migration within sinusoids 
occurs without any noticeable rolling (Lee and Kubes 2008). Leukocyte adhesion in 
sinusoids is selectin independent, probably as a consequence of the low levels of shear 
stress in the hepatic sinusoids and also little E- and P-selectin expression on the 
sinusoid endothelium (McNab et al. 1996).  
In the rat liver at steady state, both the central venules and sinusoidal endothelium 
express ICAM-1 (Iigo et al. 1997). VCAM-1 and MAdCAM-1 is not expressed in normal 
liver tissue but can be upregulated on hepatic endothelium in inflammatory conditions 
(Volpes, Van Den Oord, and Desmet 1992; Ala, Dhillon, and Hodgson 2003). 
β2 integrins mediate adhesion of leukocytes in post-sinusoidal venules, but play a less 
obvious role in sinusoids (Lee and Kubes 2008). Activated CD8+ T cells adhere to liver 
sinusoidal endothelial cells via VCAM-1/VLA-4 interactions in the absence of antigen-
dependent cues. If CD8+ T cells recognize antigens on the surface of hepatocytes or 
liver sinusoidal endothelial cells, CD8+ T cells adhere via ICAM-1/LFA-1 interactions 
(John and Crispe 2004). CXCL9 and CXCL10/CXCR3 interactions were reported to 
support the accumulation of virus-specific T cells in the murine liver (Hokeness et al. 
2007). 
29 
 
Neutrophil adhesion within liver sinusoids is mediated by ICAM-1 and CD11b/CD18 in 
sterile inflammation, while CD44 rather than CD11b/CD18 interactions with hyaluronan 
(HA) have been found to mediate the recruitment of neutrophils to the liver in response 
to infectious stimuli (McDonald et al. 2008). CXCR2 expressed on the luminal surface 
of liver sinusoids around sites of necrosis can guide neutrophil to migrate to the site of 
injury (McDonald et al. 2010).  
 
Figure 1.5 Leukocyte recruitment in liver in an inflammatory response 
The structure of hepatic sinusoidal endothelium is fenestrated and lacks a basal membrane. 
Blood flow in the liver is slow. Leukocyte recruitment in liver sinusoids is selectin-
independent. Cells adhere to liver endothelial cells by interaction between adhesion 
molecules, including α4 integrins, LFA-1, CD44, VCAM-1, ICAM-1 and HA. In mice, very 
little VAP-1 was found in liver, but it can be significantly upregulated in all vessels of the 
inflamed liver (Lee and Kubes 2008). 
 
In conclusion, leukocyte migration in liver is generally selectin-independent. ICAM-1 is 
expressed in liver endothelium and guides the CD8 T cell recruitment process, as well 
as that of neutrophils in sterile inflammation. VCAM/VLA-4 interactions contribute to 
CD8 T cell adhesion, although some studies suggest VCAM-1 was not expressed in 
liver under non-inflammatory conditions.  
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1.2.4.3. Leukocyte migration into lymph nodes 
 
Lymphocytes are being recruited from blood to lymph nodes at the site of high 
endothelial venules (HEVs) (Marchesi and Gowans 1964). The interaction between 
lymphocytes and HEVs is initiated by L-selectin on the surface of lymphocytes. CD62L 
recognizes a family of mucin-like glycoprotein (also called peripheral nodal addressins, 
PNAd), and the crucial carbohydrate determinant for recognition is called 6-sulpho 
sialyl Lewis X, which is abundantly expressed by HEVs. This apically expressed 
carbohydrate supports rolling of CD62L-high leukocytes and is crucial for homing, as 
blocking of this carbohydrate with the anti-PNAd carbohydrate epitope antibody 
MECA-79 results in a functional block of leukocyte homing to the lymph node 
(Umemoto et al. 2006).  
The next step for lymphocyte homing is to build firm adhesion due to a chemokine-
induced activation of integrins. For T cells, the most important chemokines are 
CCL21/CCL19 and CXCL12, which can be recognized by the CCR7 and CXCR4 
receptors respectively. In addition to these two receptors, B cells also express CXCR5, 
which is the receptor for CXCL13. HEV endothelial cells can abundantly express 
CCL21 (in mice, not humans) (Gunn et al. 1998), while lymph node stromal cells can 
produce CCL19, CXCL12 and CXCL13 and transcytose these molecules to the luminal 
surface of HEVs (Girard, Moussion, and Forster 2012; Okada et al. 2002; Baekkevold 
et al. 2001). These chemokine signals induce binding of LFA-1 to ICAM-1 and ICAM-
2 in peripheral lymph nodes, or α4β7 to MAdCAM-1 in mesenteric lymph nodes. By in 
vivo homing assays with lymphocytes as donor cells, overlapping effects of ICAM-1 
and ICAM-2 were found. Blocking any of these molecules alone was shown not to 
influence the recruitment of lymphocytes, while simultaneous blockade of both 
adhesion molecules could drastically decrease recruitment (Lehmann et al. 2003). 
CXCR4 was found to support a low level of T cell homing when CCR7 ligands were 
absent (as found in the PLT mouse) (Bai et al. 2009), while blocking CCR7 and CXCR4 
could block 90% of B cell migration to lymph nodes (Okada et al. 2002).  
The firm adhesion of rolling cells on the inner luminal surface of HEV enables 
leukocytes to cross the tissue either via paracellular migration or transcellular 
transmigration (Engelhardt and Wolburg 2004). The transcellular route was found to 
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be preferentially used by lymphocytes (Nieminen et al. 2006) through ICAM-1 and 
VCAM-1 enriched endothelial projections (Carman and Springer 2004). Some 
transmigrated lymphocytes were shown to accumulate in HEV pockets for several 
minutes before entering the parenchyma as a way to control the lymphocyte entry flux 
(Mionnet et al. 2011). 
 
 
Figure 1.6 Lymphocytes migration to lymph nodes 
Leukocyte recruitment from HEVs into lymph nodes through binding of CD62L to 6-sulpho 
sialyl Lewis X. Following rolling and tethering, firm adhesion by chemokine-induced 
activation of integrins is achieved by LFA-1 binding to ICAM-1 and ICAM-2. Finally, 
leukocytes transmigrate and accumulate in HEV pockets, and migrate into the lymph node 
parenchyma (Girard et al. 2012). 
 
Neutrophils are largely excluded from lymph nodes under steady-state conditions, but 
can be recruited to draining lymph nodes in response to stimuli, such as inflammation, 
through both lymphatic and blood routes. L-selectin and PSGL-1, Mac-1 and LFA-1, 
and the chemokine receptor CXCR4 help neutrophils to migrate across HEVs, whereas 
Mac-1, LFA-1 and CXCR4 are also involved in the lymphatic trafficking route (Gorlino 
et al. 2014; Hampton and Chtanova 2016). 
Taken together, lymphocytes migrate into lymph nodes from blood via HEVs. The 
recruitment process is initiated by L-selectin, followed by interaction between LFA-1 
and ICAM-1/ICAM-2 and chemokines, including CCL21/CCL19, CXCL12 and CXCL13. 
Neutrophils are recruited to lymph nodes in response to inflammatory stimuli. L-selectin, 
PSGL-1, Mac-1, LFA-1 and CXCR4 were shown to be involved in this process.   
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1.2.4.4. Leukocyte migration to the spleen 
 
The spleen is the largest secondary lymphoid organ and has a complex anatomy. It is 
composed of open-structured red pulp, which can filter blood and remove old red blood 
cell, and interwoven branches of white pulp, which is composed of lymphoid tissues. 
The red and white pulps are separated by the marginal zone, where follicular arteries 
terminate and form the sinus. Some lymphocytes together with non-lymphocytes pass 
to the outer region of the marginal zone and then to the red pulp or directly into venous 
sinuses. A fraction of lymphocytes enter the white pulp from the marginal zone and 
appear within the B and T cell areas of the white pulp cords (van Ewijk and 
Nieuwenhuis 1985; Lo, Lu, and Cyster 2003). 
The white pulp is densely populated with lymphocytes. Lymphocytes can enter the 
spleen from the marginal sinus without the help of CD44, PSGL-1, L-selectin. But 
interactions through integrin LFA-1 and VLA-4, and their ligands ICAM-1 and VCAM-1 
expressed by the sinus lining cells in the marginal zone are required. Blocking VLA-4 
alone had no measurable effect on lymphocyte accumulation in the while pulp, but 
blocking both LFA-1 and VLA-4 generated a stronger blocking effect than blocking 
LFA-1 alone, suggesting the contribution of VLA-4 to lymphocyte homing is fully 
redundant to LFA-1, while LFA-1 is partially redundant with VLA-4 (Lo, Lu, and Cyster 
2003). Although there is high expression of ICAM-1 on sinus lining cells, blocking LFA-
1 can only partly block the recruitment of leukocytes to the while pulp, and no specific 
difference for T or B cells were found (Nolte et al. 2002).  
Blocking ICAM-1 can partially reduce the number of B cells migration into white pulp 
cords. Blocking LFA-1 and VCAM-1 generated a reduction in B cells homing to the 
white pulp, better than blocking LFA-1 alone but not as severe as the combination of 
anti-VLA-4 and anti-LFA-1. MadCAM-1 is also expressed within the marginal zone, but 
no contribution was found for MAdCAM-1 or α4β7 integrin (Lo, Lu, and Cyster 2003).  
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Figure 1.7 Spleen structure 
(A) The afferent splenic artery enters the spleen and branches into central arterioles, which 
are sheathed by white-pulp areas consisting of the T-cell zone, B-cell follicles, and arterioles. 
The arterioles end in the red pulp which consists of a lot of venous sinuses. Blood from the 
arterioles and run into the sinuses, and finally collect into the efferent splenic vein. (B) 
Follicular arteries terminate in the marginal zone and form the marginal sinus. Leukocyte 
enter the white pulp through the marginal zone. Entry of the leukocyte is initiated by 
interaction of adhesion molecules. Leukocyte migrate into different zones by the guidance 
of different chemokines (Mebius and Kraal 2005).  
 
The red pulp has an open connection with the blood stream, and serves as a filter to 
remove bacterial and senescent leukocytes from blood. Some lymphocytes can be 
found localized in the red pulp, which is regarded as a passive process, but selective 
retention may also occur (Nolte et al. 2002).  
The spleen is also one of the sites to clear old neutrophils, together with the liver and 
the bone marrow. By pre-treatment of senescent neutrophils with pertussis toxin, the 
accumulation of neutrophils was decreased by 50%, indicating that neutrophil 
clearance via spleen is an active process mediated via Gαi-coupled receptors (Gordy 
et al. 2011; Furze and Rankin 2008). 
In conclusion, the spleen has two major structures, the white pulp and the red pulp. 
The migration to the white pulp is induced by the interactions of adhesion molecules, 
such as LFA-1/ICAM-1 and ICAM-2, VLA-4 and VCAM-1. However, the migration of 
leukocytes in the red pulp is considered to be a passive process.  
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1.2.4.5. Leukocyte migration to the bone 
marrow 
 
The bone marrow has two distinct blood vessel types with different permeability 
properties, less permeable arterial blood vessels and more permeable sinusoids. The 
arterial bone marrow endothelial cells (BMEC) express higher level of VCAM-1, ICAM-
1 and P-selectin, while sinusoidal BMEC express higher levels of E-selectin (Itkin et al. 
2016). However, arterial blood vessels are less permeable and experience a higher 
blood flow (Spencer et al. 2014). This is likely one of the reasons why leukocyte 
trafficking from and to bone marrow occurs exclusively at the sinusoids (Itkin et al. 
2016). 
The bone marrow is the site to clear CXCR4high senescent neutrophils, and therefore 
constitutes a major homing site for neutrophils (Furze and Rankin 2008). In vivo 
homing experiment with Indium-111 labelled neutrophils suggests that peripheral blood 
neutrophils homed significantly to both the bone marrow (approximately 31%) and the 
liver (approximately 32%) after 4 hours, and the percentage of neutrophils homed to 
bone marrow was even higher (approximately 62%) if bone marrow neutrophils were 
used as donor cells (Strydom and Rankin 2013; Suratt et al. 2001). Blocking CXCR4 
impedes with neutrophil homing to the bone marrow (Martin et al. 2003), and CXCR4 
deficient neutrophils failed to enter the bone marrow, but not the liver or the spleen 
(Casanova-Acebes et al. 2013), suggesting the recruitment process for neutrophils to 
bone marrow is CXCR4 dependent (Eash et al. 2009). 
The bone marrow is also a major reservoir and site of recruitment for central memory 
CD8+ T cells. Tcm cells arrest in bone marrow microvessels mainly by interactions 
between VLA-4 and VCAM-1. The extravasation step is chemokine dependent, since 
PTX treatment can largely inhibit Tcm  cells from emigrating (Mazo et al. 2005).  
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Figure 1.8 Bone marrow blood vessels model 
The bone marrow vasculature has two main types of blood vessels which are arterial blood 
vessels and sinusoids. Blood enters the bone marrow via the arteries. The artery branches 
to smaller arterioles, and further branch into small-diameter endosteal arterioles which 
reconnect to downstream sinusoids.  Blood flows into the central sinus and then out of the 
bone marrow (Itkin et al. 2016). 
 
To conclude, bone marrow is the major site for neutrophil homing and this process is 
CXCR4 dependent. Central CD8+ T cells also home to bone marrow by VLA-4/VCAM-
-1 interactions. The leukocyte recruitment process occurs predominantly at the site of 
sinusoids where E-selectin is expressed at higher levels. 
 
1.3. Homing zip code and circadian rhythmicity 
 
There is evidence suggesting that rhythmic expression of pro-migratory molecules is 
responsible for leukocyte migration to specific tissues in a rhythmic manner. 
Scheiermann et al described rhythmic hematopoietic cell recruitment to the bone 
marrow to be mediated by expression of P-selectin, E-selectin and VCAM-1, and 
leukocyte recruitment to skeletal muscle in a circadian manner due to rhythmic 
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expression of ICAM-1 and Ccl2 on skeletal muscle endothelium (Scheiermann et al. 
2012). However, what specific cell type is recruited to which specific tissue at what 
time depending on which molecules is unknown. The aim of this thesis was to address 
this question by using circadian rhythms as a screening tool to focus on pro-migratory 
molecules on leukocytes and endothelial cells. 
The rhythmic expression of some pro-migratory molecules is controlled by circadian 
genes (Scheiermann et al. 2012; Gibbs et al. 2014; Nguyen et al. 2013). Gibbs et al 
described pulmonary epithelial-specific ablation of Bmal1 increased expression of 
CXCL5, which induced higher neutrophil recruitment to the lung in response to LPS 
(Gibbs et al. 2014). Nguyen et al found that the internal Bmal1/Clock cycles impact on 
expression of Ccl2, which was essential for rhythmic monocyte migration (Nguyen et 
al. 2013). Scheiermann et al described rhythmic hematopoietic stem cell recruitment 
to the bone marrow and leukocyte recruitment to skeletal muscle to be abolished in 
Bmal1-/- mice (Scheiermann et al. 2012). Druzd et al found that Bmal1-deficient T cells 
lost rhythmic expression of CCR7, and lost overall rhythmicity in T cell homing to lymph 
nodes, suggesting that rhythmic expression of pro-migratory molecules guides 
leukocytes homing to lymph nodes at a specific time, and that expression of adhesion 
molecules is regulated by the circadian clock (Druzd et al. 2017). 
3-10% of all mRNAs in a given tissue show circadian rhythms in steady state, but these 
are largely non-overlapping in each tissue. Indeed, about 60% of the genes cycling in 
liver or heart are also expressed in the other tissue, but they do not cycle there, 
suggesting each tissue to have its own mechanism for the circadian regulation of 
specific genes in order to perform cellular physiological function according to each cell 
type (Panda et al. 2002; Storch et al. 2002).  
The rhythmic expression of pro-migratory molecules is not only mediated by intrinsic 
clocks, but also outside signals stemming from the SCN. Scheiermann et al found that 
enhanced adrenergic tone at night could upregulate expression of P-selectin, E-
selectin and VCAM-1 (Scheiermann et al. 2012). Gibbs et al described that systemic 
adrenal glucocorticoids activating glucocorticoid receptor could act as a circadian 
repressor of CXCL5 expression on lung epithelial club cell (Gibbs et al. 2014).  These 
findings suggest that the timely and tissue specific expression of pro-migratory 
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molecules is not only under the control of circadian genes inside the cells, but is also 
dependent on the environment.  
The hypothesis of the thesis is that rhythmic recruitment of leukocytes from blood to 
tissues contributes to a dramatic drop in the number of leukocytes in murine blood at 
night. Migration of leukocytes in a circadian manner is due to the rhythmic expression 
of specific pro-migratory molecules, which form a homing zip code that can determine 
when and to which organ leukocytes migrate. 
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Table 1.1 Summary of homing zip code for leukocytes 
Organs Leukocyte  Ligands conditions Reference 
Lung Neutrophils ICAM-1/CD11b Inflammation (Moreland et al. 
2002) 
 Lymphocytes ICAM-1  (Lehmann et al. 
2003) 
Liver Activated CD8 T 
cells 
VCAM-1/VLA-4 No antigen 
recognition 
(John and 
Crispe 2004) 
  ICAM-1/LFA-1 Antigen recognition (John and 
Crispe 2004) 
 Neutrophil ICAM-1/CD11b Sterile inflammation (McDonald et al. 
2010) 
  CD44/hyaluronan Inflammation (McDonald and 
Kubes 2015) 
Lymph node T cells L-selectin,  
ICAM-1/LFA-1, 
ICAM-2/LFA-1, 
CCR7,  
CXCR4 
 (Girard, 
Moussion, and 
Forster 2012) 
 B cells L-selectin,  
ICAM-1/LFA-1, 
ICAM-2/LFA-1, 
CCR7,  
CXCR4, 
CXCR5 
 (Girard, 
Moussion, and 
Forster 2012) 
 Neutrophils L-selectin,  
PSGL-1, 
CD11b, 
LFA-1,  
CXCR4 
Inflammation (Gorlino et al. 
2014; Hampton 
and Chtanova 
2016) 
Spleen lymphocytes ICAM-1/LFA-1, 
VCAM-1/VLA-4 
 (Lo, Lu, and 
Cyster 2003) 
Bone marrow Neutrophils CXCR4  (Martin et al. 
2003) 
 Central memory 
CD8+ T cells 
VCAM-1/VLA-4  (Mazo et al. 
2005) 
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2. Materials 
 
2.1. Animals 
 
Male C57BL/6N mice aged 7-8 weeks were purchased from Charles River 
Laboratories (Sulzfeld, Germany). Bmal1flox/flox, CD19-cre, CD4-cre, Lyz2-cre 
transgenic mice were purchased from Jackson Laboratories, and crossbred to obtain 
CD19-cre Bmal1flox/flox mice, CD4-cre Bmal1flox/flox mice, and Lyz2-cre Bmal1flox/flox mice 
in-house. Cdh5-cre/ERT2 Bmal1flox/flox mice were a gift from Eloi Montanez/Ralf Adams 
and were given intraperitoneal tamoxifen injection for five consecutive days to induce 
Cre recombinase expression. Experimental mice were male and used at 8-12 weeks 
of age, bred and fed in the Walter-Brendel Center for Experimental Medicine, LMU 
Munich, Germany.  Mice were maintained in a 12-hour light/dark cycle with ad libitum 
access to food and water. For some experiment, mice were put in cabinets to change 
the light phase in order to perform experiments with animals on different light schedules 
at the same time. All animal procedures were in accordance with German Law of 
Animal Welfare and approved by the Regierung of Oberbayern.  
 
2.2. Genotyping 
 
Primers for genotyping 
Table 2.1 Primer sequence and annealing temperature for genotyping 
Primers Sequence Annealing(°C) 
Generic cre Forward GCG GTC TGG CAG TAA AAA CTA TC 62 
Generic cre Reverse GTG AAA CAG CAT TGC TGT CAC TT  
Bmal1 flox Forward ACT GGA AGT AAC TTT ATC AAA CTG 55 
Bmal1 flox Reverse CTG ACC AAC TTG CTA ACA ATT A  
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PCR reaction mix 
Table 2.2 Reaction mix for genotyping 
Dream Taq 10 µl 
H2O 8.6 µl 
Forward primer 0.2 µl 
Reverse primer 0.2 µl 
DNA 1 µl 
 
 
2.3. Antibodies  
 
2.3.1. Flow cytometry 
 
Table 2.3 Antibody list of flow cytometry 
              h-human, m-mouse 
Antibody Dye Reactivity Isotype Clone Company 
CD3 PE/DZL594 anti-m Rat IgG2b, κ 17A2 Biolegend 
CD3ε Alexa Fluor® 488 anti-m Armenian 
Hamster IgG 
145-2C11  Biolegend 
CD4 Brilliant Violet 
570™ 
anti-m Rat IgG2a, κ RM4-5 Biolegend 
CD4 PE anti-m Rat IgG2b, κ GK1.5 Biolegend 
CD4 APC anti-m Rat IgG2b, κ GK1.5 Biolegend 
CD4 APC/Cy7 anti-m Rat IgG2b, κ GK1.5 Biolegend 
CD8a PE/Cy7 anti-m Rat IgG2a, κ 53-6.7  Biolegend 
CD8a APC/Cy7 anti-m Rat IgG2a, κ 53-6.7 Biolegend 
CD8a PE-CF594 anti-m LOU/M IgG2a, 
κ 
53-6.7 BD Bioscience 
CD8a Alexa Fluor® 700 anti-m Rat IgG2a, κ 53-6.7 Biolegend 
CD11b Alexa Fluor® 700 anti-m/h Rat IgG2a, κ M1/70 Biolegend 
CD115 PE anti-m Rat IgG2a, κ AFS98 Biolegend 
CD115 APC anti-m Rat IgG2a, κ AFS98 ebioscience 
Gr-1 PerCP/Cy5.5 anti-m Rat IgG2b, κ RB6-8C5 Biolegend 
Gr-1 FITC anti-m Rat IgG2b, κ RB6-8C5  Biolegend 
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CD45R/B220 Alexa Fluor® 488 anti-m/h Rat IgG2a, κ RA3-6B2  Biolegend 
CD45R/B220 PE/Cy7 anti-m/h Rat IgG2a, κ RA3-6B2 Biolegend 
CD45R/B220 APC-Cy7 anti-m/h Rat IgG2a, κ RA3-6B2 Biolegend 
Siglec-F Alexa Fluor® 647 anti-m Rat IgG2a, κ E50-2440 BD bioscience 
Siglec-F APC-Cy™7 anti-m LOU/M IgG2a, 
κ 
E50-2440 BD Bioscience 
NK1.1 APC anti-m Mouse IgG2b, 
κ 
PK136  Biolegend 
NK1.1 Alexa Fluor® 700 anti-m Mouse IgG2a, 
κ 
PK136 ebioscience 
NK1.1 PE/Cy7 anti-m Mouse IgG2a, 
κ 
PK136 Biolegend 
NK1.1 PE/Cy5 anti-m Mouse IgG2a, 
κ 
PK136 Biolegend 
CD45 PE/Dazzle™ 594 anti-m Rat IgG2b, κ 30-F11 Biolegend 
CD45 PE anti-m Rat IgG2b, κ 30-F11 Biolegend 
CD45 APC anti-m Rat IgG2b I3/2.3 Biolegend 
Ly6C PE anti-m Rat IgG2c, κ HK1.4 Biolegend 
Ly6G PerCP/Cy5.5 anti-m Rat IgG2a, κ 1A8 Biolegend 
I-A/I-E PE/Cy7 anti-m Rat IgG2b, κ M5/114.15.
2 
Biolegend 
CCR1 PE anti-m Rat IgG2b, κ 643854 R&D 
CCR2 Alexa Fluor® 700 anti-m Rat IgG2b, κ 475301 R&D 
CCR3 FITC anti-m Rat IgG2a, κ J073E5  Biolegend 
CCR3 PE anti-m Rat IgG2a, κ J073E5  Biolegend 
CCR4 PE/Cy7 anti-m Armenian 
Hamster IgG 
2G12  Biolegend 
CCR5 PE anti-m Armenian 
Hamster IgG 
HM-CCR5  Biolegend 
CCR6 PerCp/Cy5.5 anti-m Armenian 
Hamster IgG 
29-2L17  Biolegend 
CCR7 PE anti-m Rat IgG2a, κ 4B12  Biolegend 
CCR8 PE anti-m Rabbit IgG 1035c R&D 
CCR9 PE anti-m Rat IgG2a, κ 9B1  Biolegend 
CCR10 Alexa Fluor® 700 anti-m Rat IgG2b, κ 248918 R&D 
CXCR2 PE anti-m Rat IgG2a, κ 242216 R&D 
CXCR3 PE/Cy7 anti-m Armenian 
Hamster IgG 
CXCR3-173  Biolegend 
CXCR4 PE anti-m Rat IgG2b, κ L276F12  Biolegend 
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CXCR4 PerCP/Cy5.5 anti-m Rat IgG2b, κ L276F12  Biolegend 
CXCR5 PE anti-m Rat IgG2b, κ L138D7  Biolegend 
CXCR6 PerCP anti-m Rat IgG2b 221002 R&D 
CX3CR1 PerCP Cy 5.5 anti-m Mouse IgG2a, 
κ 
SA011F11  Biolegend 
CD11a PerCP/Cy5.5 anti-m Rat IgG2a, κ M17/4  Biolegend 
CD11b Alexa Fluor® 700 anti-m/h Rat IgG2a, κ M1/70  Biolegend 
CD11c  Alexa Fluor® 700 anti-m Armenian 
Hamster IgG 
N418  Biolegend 
CD44 PE-CF594 anti-m Rat IgG2b, κ IM7 BD Bioscience 
CD62L APC/Cy7 anti-m Rat IgG2a, κ MEL-14  Biolegend 
CD162 PE anti-m Rat IgG1 κ 2PH1 BD bioscience 
CD18 PerCP-Cy™5.5 anti-m Rat IgG2a, κ C71/16 BD Bioscience 
CD29 Alexa Fluor® 700 anti-m/r Armenian 
Hamster IgG 
HMβ1-1  Biolegend 
CD49b PE/Cy7 anti-m Rat IgM, κ DX5 Biolegend 
CD49d PerCP/Cy5.5 anti-m Rat IgG2b, κ R1-2  Biolegend 
CD49e PE-CF594 anti-m Rat IgG2a, κ 5H10-27 
(MFR5) 
BD Bioscience 
CD49f PE/Cy7 anti-m/h Rat IgG2a, κ GoH3  Biolegend 
Isotypes      
Isotype 
control 
Alexa Fluor® 700 anti-m Armenian 
Hamster IgG 
HTK888  Biolegend 
Isotype 
control 
PE anti-m Armenian 
Hamster IgG 
HTK888  Biolegend 
Isotype 
control 
Pe/Cy7 anti-m Armenian 
Hamster IgG 
HTK888  Biolegend 
Isotype 
control 
PerCp/Cy5.5 anti-m Armenian 
Hamster IgG 
HTK888  Biolegend 
Isotype 
control 
PE anti-m Mouse IgG 1, k P3.6.2.8.1 eBioscience 
Isotype 
control 
PE anti-m Rat IgG 1, k R3-34 BD bioscience 
Isotype 
control 
Alexa Fluor® 488 anti-m Rat IgG 2a, κ RTK2758  Biolegend 
Isotype 
control 
Alexa Fluor® 700 anti-m Rat IgG 2a, K eBR2a eBioscience 
Isotype 
control 
APC/Cy7 anti-m Rat IgG 2a, k RTK2758  Biolegend 
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Isotype 
control 
PE anti-m Rat IgG 2a, κ RTK2758  Biolegend 
Isotype 
control 
PE-CF594 anti-m Rat IgG2a, κ R35-95 BD Bioscience 
Isotype 
control 
PE/Cy7 anti-m Rat IgG2a, κ RTK2758 Biolegend 
Isotype 
control 
PerCp/Cy5.5 anti-m Rat IgG 2a, k RTK2758  Biolegend 
Isotype 
control 
PerCp/Cy5.5 anti-m Mouse IgG2a, 
κ 
MOPC-173 Biolegend 
Isotype 
control 
Alexa Fluor® 700 anti-m Rat IgG 2b, k RTK4530  Biolegend 
Isotype 
control 
PE anti-m Rat IgG2b, κ RTK4530  Biolegend 
Isotype 
control 
PE/Cy7 anti-m Rat IgG 2b, k RTK4530  Biolegend 
Isotype 
control 
PE CP594 anti-m Rat IgG 2b, k A95-1 R&D 
Isotype 
control 
PerCP/Cy5.5 anti-m Rat IgG 2b, k RTK4530  Biolegend 
 
 
2.3.2. Blocking Antibodies 
 
Table 2.4 Blocking antibodies 
Antibody Reactivity Isotype Clone Company 
anti-ICAM-1 anti-m Rat IgG2b YN1/1.7.4 BioXcell 
anti-ICAM-2 anti-m Rat Lewis IgG2a, κ 3C4(mIC2/4) BD bioscience 
anti-VCAM-1 anti-m Rat IgG1 M/K-2.7 BioXcell 
anti-P-selectin anti-m Rat Lewis IgG1, λ RB40.34 BD bioscience 
anti-E-selectin anti-m Rat Lewis IgG2a, κ 10E9.6 BD bioscience 
anti-L-selectin anti-m Rat IgG2a Mel-14 BioXcell 
anti-CD162 anti-m Rat IgG1 4RA10 BioXcell 
anti-CD18 anti-m Rat IgG2a M18/2 BioXcell 
anti-CD29 anti-m Rat IgG2a KMI6 BioXcell 
anti-CD49d anti-m Rat IgG2b PS/2 BioXcell 
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anti-CD11a anti-m Rat IgG2a M17/4 BioXcell 
Isotypes     
Isotype control anti-m Rat IgG2a 2A3 BioXcell 
Isotype control anti-m Rat IgG1 HRPN BioXcell 
All blocking antibodies are in no azide, low endotoxin format. 
 
 
2.3.3. Antibodies for fluorescence microscopy 
 
Table 2.5 Antibodies for fluorescence microscopy 
Antibody Dye Reactivity Isotype Clone Company 
ICAM-1 PE anti-m Rat IgG2b, κ YN1/1.7.4  Biolegend 
VCAM-1 PE anti-m Rat IgG2a, κ 429 
(MVCAM.A)  
Biolegend 
E-selectin PE anti-m Rat IgG2a, κ 10E9.6  (RUO) BD Bioscience 
P-selectin PE anti-m/h Mouse IgG1, 
κ 
Psel.KO2.3 eBioscience 
MadCAM Alexa 
Fluor® 488 
anti-m Rat IgG2a, κ MECA-367  Biolegend 
ICAM-2 Alexa 
Fluor® 488 
anti-m Rat IgG2a, κ 3C4 (MIC2/4)  Biolegend 
PNAd Biotin anti-m/h Rat IGM, κ MECA-79  Biolegend 
PECAM-1 Alexa 
Fluor® 647 
anti-m Rat IgG2a, κ MEC13.3  Biolegend 
CD44 PE anti-m/h Rat IgG2b, κ IM7  Biolegend 
Streptavidin Cy3    Biolegend 
Isotypes      
Isotype control Biotin anti-m Rat IgM, κ RTK2118 Biolegend 
Isotype control PE anti-m Rat IgG 2a, κ RTK2758  Biolegend 
Isotype control PE anti-m Rat IgG2b, κ RTK4530  Biolegend 
Isotype control Alexa 
Fluor® 488 
anti-m Rat  IgG 2a, 
κ 
RTK2758  Biolegend 
Isotype control PE anti-m Rat IgG 1, k P3.6.2.8.1 eBioscience 
 
 
45 
 
2.4. Blocking chemicals 
 
Table 2.6 Blocking chemicals 
Antagonist Product name Company 
CCR1 J113863 Tocris 
CCR2 RS 504393 Tocris 
CCR3 SB 328437 Tocris 
CCR4 C 021 dihydrochloride Tocris 
CXCR2 SB 265610 Tocris 
CXCR3 (±)-AMG 487 Tocris 
CXCR4 AMD 3100 octahydrochloride Tocris 
 
 
2.5. Primers for qPCR 
 
Table 2.7 Primer list for qRCR 
Primers Sequence Annealing(°C) 
Bmal1 Forward AGA GGT GCC ACC AAC CCA TA 62 
Bmal1 Reverse TGA GAA TTA GGT GTT TCA GTT CGT CAT  
Clock Forward CAA AAT GTC ACG AGC ACT TAA TGC 62 
Clock Reverse ATA TCC ACT GCT GGC CTT TGG  
Per1 Forward TGA GAG CAG CAA GAG TAC AAA CTC A 60 
Per1 Reverse CTC GCA CTC AGG AGG CTG TAG  
Per2 Forward GTC CAC CTC CCT GCA GAC AA 60 
Per2 Reverse TCA TTA GCC TTC ACC TGC TTC AC  
Cry1 Forward CTC GGG TGA GGA GGT TTT CTT 62 
Cry1 Reverse GAC TTC CTC TAC CGA GAG CTT CAA  
Nr1d1 Forward GAT AGC TCC CCT TCT TCT GCA TCA TC 60 
Nr1d1 Reverse TTC CAT GGC CAC TTG TAG ACT TC  
*All primers were purchased from Eurofins Genomics. 
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2.6. Cell and RNA isolation Kits 
 
Table 2.8 Cell and RNA isolation kits 
EasySep mouse neutrophil enrichment Kit STEMCELL Technologies 
EasySep mouse monocyte isolation Kit STEMCELL Technologies 
EasySep mouse B cell isolation kit STEMCELL Technologies 
RNeasy Plus mini Kit Qiagen Hilden Germany 
 
 
2.7. Buffers 
 
Table 2.9 RBC lysis buffer 
RBC lysis buffer(1X) 1000 ml 
NH4Cl 8.26 g 
KHCO3 1.00 g 
0.5M EDTA (pH8) 100 µl 
H2O 1000 ml 
pH 7.2-7.4  
 
Table 2.10 PEB buffer 
PEB buffer                        1 L 
EDTA                                         2 mM 
Bovin Serum Albumin                 5 g 
20%NaN3                                           2.5 ml 
PBS                                             1L 
 
Table 2.11 Tissue digestion buffer 
Tissue digestion buffer    60 ml 
12mg/ml Collagenase IV           4 ml 
10ml/ml DNase                          1.2 ml 
PBS                                          54.8 ml 
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Table 2.12 Cell incubation buffer 
Cell incubation buffer       500 ml 
0.5M EDTA                              2 ml 
BSA                                          1 g 
PBS                                           500 ml 
 
Table 2.13 DAPI buffer 
DAPI buffer                     50 ml 
DAPI (5mg/ml)                                         13.76 µl 
PEB buffer                                 50 ml 
 
Table 2.14 Tissue digestion buffer 
Animal tissue digestion buffer for genotyping 1000 ml 
100 ml Tris (1M) pH8.5 100 ml 
10 ml 0.5M EDTA 10 ml 
10%SDS 20 ml 
5M NaCl 40 ml 
 
 
 
2.8. Software 
 
Table 2.15 Software used for analyses 
Software Application 
GraphPad Prism7 Statistical analysis 
Flowjo Flow cytometry data analysis 
Zeiss Quantification of images 
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2.9. Equipment 
 
 
Table 2.16 Equipment used for experiments 
StepOnePlus Real-Time RCR System Applied Biosystems 
Gallios Flow Cytometer Beckman Coulter 
IDEXX ProCyte DX cell counter IDEXX Ludwigsburg Germany 
Cryostat Leica 
NanoDrop 2000 Thermo Scientific 
Z-Series Coulter Counter Beckman coulter 
2702 thermal cycler Applied Biosystem 
 
 
 
 
 
 
2.10. Other substances 
 
Table 2.17 Other substances used in experiments 
CFSE Thermo Fisher Scientific 
Cell tracker Deep red Thermo Fisher Scientific 
EDTA Invitrogen 
DMSO Sigma 
BSA Sigma 
DAPI Biolegend 
Gel red Biotrend 
Dreamtaq Thermo Fisher Scientific 
Gene ruler 6X Thermo Fisher Scientific 
Loading buffer Thermo Fisher Scientific 
OCT Laborversand.de and Science services 
Collagenase IV Sigma 
DNase Roche 
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3. Methods 
 
3.1. Flow cytometry 
 
3.1.1. Preparation of samples for flow cytometry 
 
3.1.1.1. Peripheral blood  
 
Mice were anesthetized by inhalation of isoflurane. Blood was collected by bleeding 
from the retro-orbital plexus into EDTA-coated capillary tubes. Leukocyte counts were 
obtained using an IDEXX ProCyte DX cell counter. Blood samples were subjected to 
erythrocyte lysis by incubation in 5ml RBC lysis buffer for 5 min at room temperature. 
5ml PBS were added to stop the lysis reaction. Leukocytes were spun down at 1300 
rpm for 5min at 4°C, and resuspended in 5ml RBC lysis buffer for a second lysis 
process on ice. After the second centrifugation, leukocytes were resuspended in PEB 
buffer, and stained with fluorescence-conjugated antibodies for 30 min on ice. After 
washing with PBS, cells were resuspended in DAPI buffer, and analyzed by flow 
cytometry using a Gallios Flow Cytometer. 
 
3.1.1.2. Lymph node and thymus 
 
Lymph nodes and thymi were harvested from animals and processed through a cell 
strainer (40 µm, Thermo Fisher Scientific). Cells were spun down at 1300 rpm for 5 
min at 4°C. Cells were resuspended in PEB buffer and stained with fluorescence-
conjugated antibodies for 30 min on ice. After washing with PBS, cells were 
resuspended in DAPI buffer and analyzed by flow cytometry using a Gallios Flow 
Cytometer.  
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3.1.1.3. Spleen and bone marrow 
 
Spleens were harvested from animals and processed through a cell strainer (40 µm, 
Thermo Fisher Scientific). Bone marrow cells were harvested from either one femur 
only or two femurs and two tibias by flushing the bone gently with cold PBS. Cells were 
spun down at 1300 rpm for 5 min at 4°C. The supernatant was removed and cells were 
resuspended in 5 ml RBC lysis buffer. After 5 min, 5 ml PBS was added and the white 
blood cell population was separated by centrifugation at 1300 rpm for 5min at 4°C. 
Cells were resuspended in PEB buffer and stained with fluorescence-conjugated 
antibodies for 30 min on ice. Cells were washed with PBS, resuspended in DAPI buffer 
and analyzed by flow cytometry using a Gallios Flow Cytometer. 
 
3.1.1.4. Lung and liver 
 
Lung and liver were first chopped into small pieces in DPBS with calcium and 
magnesium (Sigma), incubated for 1 h in digestion buffer with 1 mg/ml collagenase IV 
(Sigma) and 0.2 mg/ml DNase (Roche) at 37°C with gentle agitation. After digestion, 
cells were filtered through a 40 µm cell strainer (Thermo Fisher Scientific) and spun 
down at 1300 rpm for 5 min at 4°C. The supernatant was removed, cells were 
resuspended in 5 ml RBC lysis buffer and incubated for 5 min on ice. After adding 5 ml 
PBS, cells were spun down at 1300 rpm for 5 min at 4°C and resuspended in PBS 
supplemented with 2% FBS. Cells were stained with fluorescence-conjugated 
antibodies for 30 min and washed with PBS, resuspended in DAPI buffer and analyzed 
by flow cytometry using a Gallios Flow Cytometer.  
All organ numbers were quantified using an automated cell counter (Z2 Coulter Particle 
Counter, Beckman Coulter). 
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3.1.2. Surface expression analyses of leukocytes 
 
Expression levels of adhesion molecules and chemokine receptors on blood 
leukocytes were measured by flow cytometry at multiple time points across the day 
and compared with isotype control using mean florescence intensity (MFI). Blood was 
collected and prepared as described before. Major leukocyte subsets in blood were 
identified by specific surface markers. 
 
Figure 3.1 Gating leukocyte subsets 
Blood cells were gated from live cells and singlets. Then leukocyte subsets were identified 
by different combinations of antibodies. CD115 and Gr-1 for differentiation of neutrophils; 
inflammatory monocytes (IM) and non-inflammatory monocytes (NIM); CD4, CD8 and B220 
for identifying lymphocytes; NK1.1 and CD3 for NK cells and NKT cells; Siglec-F and CCR3 
were used for eosinophil.  
 
Table 3.1 Antibodies for surface expression of adhesion molecules and chemokine receptors. 
Antibody Dye Reactivity Isotype Clone Company 
Siglec F Alexa 647 anti-m Rat IgG2a, κ E50-2440 
RUO 
BD bioscience 
CCR3 FITC anti-m Rat IgG2a, κ J073E5  Biolegend 
NK1.1 APC anti-m Mouse IgG2b, κ PK136  Biolegend 
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CD3ε Alexa Fluor® 488 anti-m Armenian 
Hamster IgG 
145-2C11  Biolegend 
CD115 APC anti-m Rat IgG2a, κ AFS98 ebioscience 
Gr-1 FITC anti-m Rat IgG2b, κ RB6-8C5  Biolegend 
CD45R/B220 Alexa Fluor® 488 anti-m/h Rat IgG2a, κ RA3-6B2  Biolegend 
CD4 APC anti-m Rat IgG2b, κ GK1.5 Biolegend 
CD8a PE/Cy7 anti-m Rat IgG2a, κ 53-6.7  Biolegend 
CCR1 PE anti-m Rat IgG2b, κ 643854 R&D 
CCR2 Alexa Fluor® 700 anti-m Rat IgG2b, κ 475301 R&D 
CCR3 FITC anti-m Rat IgG2a, κ J073E5  Biolegend 
CCR3 PE anti-m Rat IgG2a, κ J073E5  Biolegend 
CCR4 PE/Cy7 anti-m Armenian 
Hamster IgG 
2G12  Biolegend 
CCR5 PE anti-m Armenian 
Hamster IgG 
HM-CCR5  Biolegend 
CCR6 PerCp/Cy5.5 anti-m Armenian 
Hamster IgG 
29-2L17  Biolegend 
CCR7 PE anti-m Rat IgG2a, κ 4B12  Biolegend 
CCR8 PE anti-m Rabbit IgG 1035c R&D 
CCR9 PE anti-m Rat IgG2a, κ 9B1  Biolegend 
CCR10 Alexa Fluor® 700 anti-m Rat IgG2b, κ 248918 R&D 
CXCR2 PE anti-m Rat IgG2a, κ 242216 R&D 
CXCR3 PE/Cy7 anti-m Armenian 
Hamster IgG 
CXCR3-173  Biolegend 
CXCR4 PE anti-m Rat IgG2b, κ L276F12  Biolegend 
CXCR4 PerCP/Cy5.5 anti-m Rat IgG2b, κ L276F12  Biolegend 
CXCR5 PE anti-m Rat IgG2b, κ L138D7  Biolegend 
CXCR6 PerCP anti-m Rat IgG2b 221002 R&D 
CX3CR1 PerCP Cy 5.5 anti-m Mouse IgG2a, κ SA011F11  Biolegend 
CD11a PerCP/Cy5.5 anti-m Rat IgG2a, κ M17/4  Biolegend 
CD11b Alexa Fluor® 700 anti-m/h Rat IgG2a, κ M1/70  Biolegend 
CD11c  Alexa Fluor® 700 anti-m Armenian 
Hamster IgG 
N418  Biolegend 
CD44 PE-CF594 anti-m Rat IgG2b, κ IM7 BD Bioscience 
CD62L APC/Cy7 anti-m Rat IgG2a, κ MEL-14  Biolegend 
CD162 PE anti-m Rat IgG1 κ 2PH1 BD bioscience 
CD18 PerCP-Cy™5.5 anti-m Rat IgG2a, κ C71/16 BD Bioscience 
CD29 Alexa Fluor® 700 anti-m/r Armenian 
Hamster IgG 
HMβ1-1  Biolegend 
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CD49b PE/Cy7 anti-m Rat IgM, κ DX5 Biolegend 
CD49d PerCP/Cy5.5 anti-m Rat IgG2b, κ R1-2  Biolegend 
CD49e PE-CF594 anti-m Rat IgG2a, κ 5H10-27 
(MFR5) 
BD Bioscience 
CD49f PE/Cy7 anti-m/h Rat IgG2a, κ GoH3  Biolegend 
 
 
3.1.3. Adoptive transfer and homing assay of 
leukocytes 
 
3.1.3.1. Adoptive transfer and peripheral blood 
 
To investigate the recruitment of leukocytes from the blood to tissues, adoptive transfer 
experiments were performed and donor cells left in blood were measured as a negative 
indicator of how many cells had migrated into tissues. First, donor cells were obtained 
from bone marrow and spleen from donor mice. Single cell suspensions were made 
by flushing bone marrow with cold PBS and smashing spleen gently through a 40 µm 
cell strainer (Thermo Fisher Scientific). Cells were lysed with red cell lysis buffer for 5 
min, then 5 ml PBS were added to stop the lysis reaction. Cells were spun down at 
1300 rpm for 5 min and resuspended in cell incubation buffer (PBS, 0.2%BSA, 2mM 
EDTA) and counted on a cell counter (ProCyte DX cell counter). Bone marrow and 
spleen cells were mixed with a ratio of 50:50, and labeled with 1.5 µM CFSE or 0.1 µM 
CellTracker Deep Red dye for 20 min at 37 °C. After washing 3 times with PBS, cells 
were resuspended in PBS and 20X106 cells were injected intravenously in each 
recipient mouse. After one hour, blood was harvested from recipient mice and 
processed as described before for flow cytometry analyses. 
For identifying different leukocyte subsets of remaining injected cells in blood, cells 
were gated from total CFSE or CellTracker Deep Red positive cells, from which various 
leukocyte subsets were differentiated by specific surface markers as below. 
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Table 3.2 Flow cytometry panel for blood staining with CFSE donor cells 
Antibody Dye Reactivity Isotype Clone Company 
Siglec-F Alexa Fluor® 647 anti-m Rat IgG2a, κ E50-2440 BD bioscience 
NK1.1 Alexa Fluor® 700 anti-m Mouse IgG2a, κ PK136 ebioscience 
CD3 PE/DZL594 anti-m Rat IgG2b, κ 17A2 Biolegend 
CD115 PE anti-m Rat IgG2a, κ AFS98 Biolegend 
Gr-1 PerCP/Cy5.5 anti-m Rat IgG2b, κ RB6-8C5 Biolegend 
CD45R/B220 PE/Cy7 anti-m/h Rat IgG2a, κ RA3-6B2 Biolegend 
CD4 Brilliant Violet 
570™ 
anti-m Rat IgG2a, κ RM4-5 Biolegend 
CD8a APC/Cy7 anti-m Rat IgG2a, κ 53-6.7 Biolegend 
DAPI     Biolegend 
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Figure 3.2 Gating strategy of adoptive transfer experiment with CFSE donor cells 
 
 
 
56 
 
Table 3.3 Flow cytometry panel for blood staining with CFSE and CellTracker Deep Red donor 
cells 
Antibody Dye Reactivity Isotype Clone Company 
Siglec-F APC-Cy™7 anti-m LOU/M IgG2a, κ E50-2440 BD Bioscience 
NK1.1 Alexa Fluor® 700 anti-m Mouse IgG2a, κ PK136 ebioscience 
CD115 PE anti-m Rat IgG2a, κ AFS98 Biolegend 
Gr-1 PerCP/Cy5.5 anti-m Rat IgG2b, κ RB6-8C5 Biolegend 
CD45R/B220 PE/Cy7 anti-m/h Rat IgG2a, κ RA3-6B2 Biolegend 
CD4 Brilliant Violet 570™ anti-m Rat IgG2a, κ RM4-5 Biolegend 
CD8a PE-CF594 anti-m LOU/M IgG2a, κ 53-6.7 BD Bioscience 
DAPI     Biolegend 
 
 
3.1.3.2. Homing assay and organ analysis 
 
For homing assays to organs, donor cells were prepared as describe before (3.1.3.1). 
One hour after the injection of cells, organs were harvested. Various leukocyte subsets 
were identified by surface makers, and then donor cells were differentiated by CFSE 
and Deep red dyes. For the spleen, bone marrow and lymph nodes, we used the same 
panel as for blood (Table 3.3). For the Lung and liver, two flow cytometry panels were 
applied (Table 3.4 and Table 3.5).  
Table 3.4 Antibody panel for homing experiment to lung and liver group 1 
Antibody Dye Reactivity Isotype Clone Company 
CFSE           
CD45 
PE/Dazzle™ 
594  anti-m Rat IgG2b, κ 30-F11 Biolegend 
Ly6C PE anti-m Rat IgG2c, κ HK1.4  Biolegend 
Ly6G  PerCP/Cy5.5 anti-m Rat IgG2a, κ 1A8 Biolegend 
I-A/I-E  PE/Cy7 anti-m Rat IgG2b, κ 
 
M5/114.15.2 Biolegend 
NK1.1  PE/Cy7  anti-m 
Mouse IgG2a, 
κ PK136 Biolegend 
Deep red           
CD11b 
Alexa Fluor® 
700 anti-m/h Rat IgG2a, κ M1/70  Biolegend 
Siglec-F  APC-Cy™7 anti-m 
LOU/M IgG2a, 
κ E50-2440 BD Bioscience 
DAPI           
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Figure 3.3 Gating strategy of organs to identify homed myeloid cells : lung  
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Table 3.5 Antibody panel for homing experiment to lung and liver group 2 
Antibody Dye Reactivity Isotype Clone Company 
CFSE      
CD8a PE-CF594 anti-m LOU/M IgG2a, 
κ 
53-6.7 BD Bioscience 
CD4 PE anti-m Rat IgG2b, κ GK1.5 Biolegend 
NK1.1 PE/Cy5 anti-m Mouse IgG2a, 
κ 
PK136 Biolegend 
CD45 PE-cy7 anti-m Rat IgG2b, κ 30-F11 Biolegend 
Deep red      
CD45R/B220 APC-Cy7 anti-m/h Rat IgG2a, κ RA3-6B2 Biolegend 
DAPI      
 
 
Figure 3.4 Gating strategy of organs to identify homed lymphocytes and NK cells: lung 
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In some experiment, injection of CD45 antibody (clone I3/2.3) followed by perfusion 
were performed in order to clean organs from blood and distinguish between cells 
adherent to the vascular endothelium or located extravascularly. Injection of donor 
cells was performed as described before. After one hour, 10 µl CD45 (clone I3/2.3) in 
200 µl PBS were injected intravenously to recipient mice. 3 minutes later, mice were 
killed using an overdose of isoflurane and perfused with 10 ml PBS, 5 ml from the left 
ventricle and 5 ml from the right ventricle in order to perfuse the whole body and the 
lung, respectively. Organs were harvested and processed as described before. CD45 
PE/Dazzle™ 594 FL3 (clone 30-F11) antibody was use for staining total CD45 positive 
cells, while cells only adherent to vessel endothelium were identified by staining with 
an injected i.v. CD45 APC FL6 (clone I3/2.3) antibody. Total injected donor cells were 
further differentiated into various leukocyte subsets by specific surface markers as 
below (Table 3.6 Figure 3.5). 
Table 3.6 Flow cytometry panel for homing assay staining 
Antibody Dye Reactivity Isotype Clone Company 
Ly6C PE anti-m Rat IgG2c, κ HK1.4 Biolegend 
CD45 PE/Dazzle™ 594 anti-m Rat IgG2b, κ 30-F11 Biolegend 
Ly6G PerCP/Cy5.5 anti-m Rat IgG2a, κ 1A8 Biolegend 
CD45R/B220 PE/Cy7 anti-m/h Rat IgG2a, κ RA3-6B2 Biolegend 
CD45 APC anti-m Rat IgG2b I3/2.3 Biolegend 
CD8a Alexa Fluor® 700 anti-m Rat IgG2a, κ 53-6.7 Biolegend 
CD4 APC/Cy7 anti-m Rat IgG2b, κ GK1.5 Biolegend 
DAPI     Biolegend 
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Figure 3.5 Gating strategy of homing experiment to organs 
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3.1.3.3. Blocking functions of pro-migratory 
molecules 
 
To investigate the role of specific pro-migratory molecules in a rhythmic homing 
process, antibody or antagonist experiments were performed in combination with 
adoptive transfer experiments or homing assays. Blocking antibodies or chemokine 
antagonists were diluted into working concentrations with PBS or 5% DMSO with 1% 
Tween80 (Sigma) and injected i.v. or i.p. to recipient mice 2 hours before injection of 
donor cells. The following steps were performed as described above. The volumes of 
each antibody or chemical were listed as below: 
Table 3.7 Antibodies and chemicals for function blocking experiments 
Antibodies or chemicals Volume medium Injection 
anti-ICAM-1 200 µg/mouse PBS i.v. 
anti-ICAM-2 60 µg/mouse PBS i.v. 
anti-VCAM-1 200 µg/mouse PBS i.v. 
anti-P-selectin 30 µg/mouse PBS i.v. 
anti-CD62E 50 µg/mouse PBS i.v. 
anti-CD62L 200 µg/mouse PBS i.v. 
anti-PSGL-1 200 µg/mouse PBS i.v. 
anti-CD18 200 µg/mouse PBS i.v. 
anti-CD29 200 µg/mouse PBS i.v. 
anti-CD49d 100 µg/mouse PBS i.v. 
anti-CD11a 100 µg/mouse PBS i.v. 
Isotype control  200 µg/mouse PBS i.v. 
CCR1 125 µg/mouse 5% DMSO  with 1% Tween80 i.p. 
CCR2 125 µg/mouse 5% DMSO  with 1% Tween80 i.p. 
CCR3 125 µg/mouse 5% DMSO  with 1% Tween80 i.p. 
CCR4 125 µg/mouse PBS i.p. 
CXCR2 125 µg/mouse 5% DMSO  with 1% Tween80 i.p. 
CXCR3 125 µg/mouse 5% DMSO  with 1% Tween80 i.p. 
CXCR4 125 µg/mouse PBS i.p. 
control 200 µl 5% DMSO  with 1% Tween80 i.p. 
control 200 µl PBS i.p. 
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3.1.4. Human peripheral blood experiment 
 
Human blood was taken by finger puncture and collected into a EDTA coated tube 
(SARSTEDT, Germany). Blood was prepared as described before (3.1.1.1) and 
stained with antibodies (Table 3.8) in room temperature for 30 min. Human experiment 
was conducted according to the ethical principles. 
Table 3.8 Antibodies for human blood staining 
Antibody Dye Reactivity Isotype Clone Company 
CD8 Alexa Fluor® 488 anti-human Mouse IgG1, κ HIT8a Biolegend 
CD19 PE anti-human Mouse IgG1, κ HIB19 Biolegend 
CD56 PE/Dazzle™ 594 anti-human Mouse IgG1, κ HCD56 Biolegend 
CD14 PerCP/Cy5.5 anti-human Mouse IgG1, κ HCD14 Biolegend 
CD16 PE/Cy7 anti-human Mouse IgG1, κ 3G8 Biolegend 
CD49d APC anti-human Mouse IgG1, κ 9F10 Biolegend 
CD4 Alexa Fluor® 700 anti-human Mouse IgG1, κ SK3 Biolegend 
CXCR4 APC/Cy7 anti-human Mouse IgG2a, κ 12G5 Biolegend 
CD3 Brilliant Violet 570™ anti-human Mouse IgG1, κ UCHT1 Biolegend 
DAPI     Biolegend 
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Figure 3.6 Gating strategy of human blood. 
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3.2. Cell isolation 
 
Spleen B cells were purified from CD19-cre Bmal1flox/flox or littermate control mice using 
a EasySep mouse B cell isolation kit (STEMCELL Technologies) according to the 
manufacturer’s protocol, and purity (~92%) was accessed by flow cytometry. Bone 
marrow monocytes and neutrophils were purified from Lyz2-cre Bmal1flox/flox or 
littermate control mice using a monocyte isolation kit and a neutrophil enrichment kit 
(STEMCELL Technologies) respectively. Purity of monocytes was about 93% and of 
neutrophils around 82%. 
 
3.3. Q-PCR 
 
RNA was extracted from isolated cells using RNeasy Plus mini Kit (Qiagen Hilden 
Germany) following the manufacturers’ instructions. RNA samples were analyzed 
using NanoDrop2000 (Thermo Scientific) to determine RNA concentration and quality. 
RNA was stored at -80°C. 
For reverse transcription, 150-200 ng RNA was added for reverse transcription, using 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). cDNA 
samples were stored at -20°C prior to use in quantitative PCR (Q-PCR). Q-PCR was 
performed with StepOnePlus Real-Time PCR System (Applied Biosystems) in 96-well 
plates with SYBR green compatible primers. The cycling conditions are listed below. 
Duplicates or triplicates were performed for each qPCR samples. The total reaction 
volume was 10 µl, containing 5 µl SYBR green, 1 µl primer mix (5 µM), 2 µl H20 and 2 
µl cDNA.  Gene expression levels were normalized to the housekeeping gene GAPDH.  
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Table 3.9 Cycling conditions for qPCR 
Cycling conditions Temperature Time 
Initial denaturation 95°C 10 min 
Denaturation  95°C 15 s 
Annealing 60-62°C 1 min 
Extension 72°C 15 s 
Final extension 72°C 7 min 
 
 
 
3.4. Immunofluorescence staining and quantitative 
imaging analyses  
 
To measure adhesion molecule expression levels on endothelial cells, animal organs 
were put in to OCT, frozen at -80°C and sectioned with a thickness of 10 µm on a 
cryostat (Leica). Sections were fixed with cold methanol for 10 min at room 
temperature, incubated in PBS containing Triton X-100 (0.5%), and normal goat serum 
(20%). Sections were stained with antibodies and incubated at 4°C overnight.  
For investigation of protein expression levels on the endothelium, images were 
obtained using a Zeiss Axio Examiner.D1 microscope equipped with 405, 488, 563 and 
655 nm LED excitation light sources. All quantifications were performed using mask 
analyses with Zeiss software based on PECAM-1 expression as shown below. First, 
vascular endothelium was identified by PECAM-1+ expression, and this area was then 
covered by a mask. Quantifying expression of other florescent channels within this 
mask was then performed (Figure 3.7).  
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Figure 3.7 Surface expression measurements on liver endothelium 
(A) Representative image of a frozen section from liver stained for PECAM-1 (Green) and 
ICAM-1 (Red) (B) The endothelial area for the mask analysis is indicated by a red shape. 
(C) The PECAM-1+ endothelial cell area (yellow area) was created as a mask by for further 
analysis.  
 
PECAM-1+ areas (see Figure 3.3C) smaller than 10 µm2 were excluded from analysis 
to minimize non-specific signals. Protein expression levels were presented as mean 
fluorescence intensity (MFI) within the mask area and after subtraction of isotype 
controls (Figure 3.8). 
 
Figure 3.8 MFI data results  
Adhesion molecule expression levels in PECAM-1+ areas are represented by mean 
fluorescence intensities (MFI) of the stained antibody. Column B shows the size of the 
PECAM+ endothelium area, column C shows the MFI of ICAM-1, and column D shows the 
MFI of PECAM-1 in this area. 
 
 
3.5. Genotyping 
 
Genotyping samples from transgenic mice were collected by ear punches. Tissue 
samples were stored at -20°C prior to DNA extraction  
DNA extraction began with incubation of tissue samples in 250 μl animal tissue lysis 
buffer and 1μl proteinase K in a thermomixer at 55°C at 500 rpm overnight. Following 
incubation, the pellet of the digested tissue was centrifuged down, the supernatant was 
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transferred to 100 µl isopropanol. After shaking a few times, DNA samples were 
centrifuged down for 10 min, and supernatant was discarded before adding 100 µl EB 
buffer. Samples were put in thermomixer at 37°C for 1 hour for dissolving. DNA 
samples were stored at -20°C prior to use in genotyping PCR reactions. 
PCR were performed using a PCR machine (2702 thermal cycler, Applied Biosystem). 
And the reverse transcription protocols were listed below. 
Table 3.10 RCR conditions for cre 
Cre  
Number of cycles  35 
Initial denaturation 95°C  3 min 
Denaturation 95°C  20 sec 
Annealing 62°C  30 sec 
Extension 72°C  30 sec 
Final extension 72°C  10 min 
 
Table 3.11 PCR conditions for Bmal1 
Bmal1  
Number of cycles 35 
Initial denaturation 94°C  3 min 
Denaturation 94°C  30 sec 
Annealing 55°C  30 sec 
Extension 72°C   30 sec 
Final extension 72°C  2 min 
 
All PCR products were run on a 1% agarose-TAE gel containing gel red (Biotrend) to 
visualize DNA bands. Electrophoresis was performed in TAE buffer at 120V for 30 min. 
Gene ruler 6X was used to allow determination of fragment sizes.  
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3.6. Statistics  
 
Data was analyzed using Prism 7 (GraphPad), and presented as mean +/- standard 
error of mean (SEM). A p value less than 0.05 was considered as statistically 
significant. Comparison between two groups were performed using unpaired Student’s 
t test. One-way ANOVA analysis followed by Tukey’s multiple comparison test was 
used for multiple group comparison. One-way ANOVA analysis followed by Dunnett’s 
test was used for comparison between control and treatment groups. Human data was 
analyzed by repeated measures of one-way ANOVA.  
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4. Results 
 
4.1. Oscillations in circulating leukocyte subsets are 
governed by a rhythmic homing process 
 
4.1.1. Circulating subsets oscillate during 24 hours 
 
All work presented in this thesis is currently prepared for submission as a first author 
publication.  
To first assess whether leukocyte subsets oscillate over 24 hours, blood was harvested 
every four hours from mice which were kept in 12h light:12h dark cycles. Total white 
blood cell numbers were counted and leukocyte subset percentages were obtained by 
flow cytometry analysis. We found that the total white blood cell count showed dramatic 
oscillations during 24 hours, with a trough at ZT13 (i.e. 8pm), which is one hour after 
lights off, when mice become active, and a peak at ZT5 (i.e. 12pm), when mice are in 
their resting phase (Figure 4.1). Numbers of neutrophils, B cells, CD8 and CD4 T cells, 
Natural Killer (NK) cells, Natural Killer T (NKT) cells, inflammatory monocytes (IM) and 
non-inflammatory monocytes (NIM) as well as eosinophils showed similar oscillation 
patterns (Figure 4.1).  
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Figure 4.1 Oscillations in total white blood cell and leukocyte subset counts 
Total leukocyte counts and leukocyte subsets, including neutrophils, B cells, CD8 T cells, 
CD4 T cells, NK cells, NKT cells, IM (inflammatory monocytes), NIM (non-inflammatory 
monocytes), and eosinophils, exhibit circadian number changes. Zeitgeber time (time after 
light onset). ZT1 is double plotted to facilitate viewing. n=9-62, one-way ANOVA. *p<0.05, 
***p<0.001, ****p<0.0001 (manuscript in preparation). 
 
 
4.1.2. The microenvironment contributes to 
rhythmic leukocyte homing  
 
We next investigated whether the oscillation of leukocyte blood counts was due to 
rhythmic homing, and furthermore, whether the microenvironment contributes to this 
process. We performed ‘negative’ homing assays where we collected donor cells from 
ZT1 mice, incubated these with CFSE, and injected them at the same time into 6 
groups of mice kept at different light phases (ZT1, ZT5, ZT9, ZT13, ZT17 and ZT21). 
After letting donor cells circulate for one hour, we measured the number of donor cells 
left in recipients’ blood (Figure 4.2). By keeping the donor constant and changing the 
recipients only, we were able to decipher the role of time-dependent microenvironment 
factors. 
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Figure 4.2 Adoptive transfer experiment with recipients kept at different phases 
Spleen and bone marrow cells were collected from donor mice at the ZT1 time point. After 
incubation with CFSE, cells were injected into recipients at various time points, namely ZT1, 
ZT5, ZT9, ZT13, ZT17, ZT21. One hour later, blood was harvested and analyzed by flow 
cytometry. 
 
Donor cells left in recipients’ blood showed lowest numbers at ZT13, indicating that a 
rhythmic microenvironment contributes to cells leaving the circulation either by having 
migrated into tissues or by being in firm contact with the endothelium. There were more 
than 2-fold time-of-day differences in the capacity of every leukocyte subset to 
emigrate out from blood, suggesting that the microenvironment at the ZT13 time point 
was most permissive to the cells’ migration (Figure 4.3).  
 
Figure 4.3 A rhythmic microenvironment contributes to leukocyte number oscillation in 
peripheral blood 
Donor cells left in blood showed differences between different time points. Total donor cells 
as well as neutrophils, B cells, CD4 T cells, CD8 T cells, NK cells, IM (inflammatory 
monocytes), NIM (non-inflammatory monocytes), eosinophils, all leave the circulation at a 
higher rate at ZT13. n=3-25, one-way ANOVA. **p<0.01, ***p<0.001, ****p<0.0001 
(manuscript in preparation). 
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4.1.3. Leukocytes contribute to rhythmic homing 
 
In addition to the microenvironment, migration of leukocytes also depends on various 
pro-migratory molecules expressed on the surface of leukocytes themselves.  
Therefore, we next investigated whether leukocytes also play an important role in 
rhythmic migration. This time we changed the time of donor cells but kept the recipients 
constant. Donor cells from mice were harvested at ZT1, 5, 9, 13 and 21, incubated with 
CFSE and injected i.v. into ZT5 recipient mice (Figure 4.4).  
 
Figure 4.4 Adoptive transfer experiment with recipients kept in one phase 
Spleen and bone marrow cells were collected from mice at ZT1, ZT5, ZT9, ZT13, ZT21 time 
points as donor cells. After incubation in CFSE, donor cells were injected into ZT5 recipients. 
One hour later, blood was harvested and analyzed by flow cytometry.  
 
The donor cells left in blood showed the lowest number at ZT13, suggesting that donor 
cells at the ZT13 time point can leave blood more easily than at any other time of the 
day. The same phenomenon was found for each leukocyte subset (Figure 4.5). This 
finding indicates that donor cells at different time points have distinct recruitment 
capacities. 
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Figure 4.5 Rhythmic recruitment governed by donor cells contributes to the leukocyte number 
oscillation in peripheral blood 
Donor cells left in blood showed oscillations during 24 hours. Donor cells from ZT13 mice 
leave the circulation better than at any other time point. This was observed for neutrophils, 
B cells, CD4 T cell, CD8 T cells, NK cells, IM (inflammatory monocytes), NIM (non-
inflammatory monocytes), eosinophils. n=3-17, one-way ANOVA. *p<0.05, **p<0.01, 
***p<0.001(manuscript in preparation). 
 
 
 
4.1.4. Both the microenvironment and the 
leukocyte contribute to rhythmic leukocyte 
migration 
 
Both the microenvironment and the leukocytes contribute to the rhythmic migration of 
leukocytes. We confirmed these observations by using reciprocal homing assays. We 
labeled ZT5 and ZT13 donor cells with CFSE (green) or Cell tracker deep red (red), 
and then injected them together into ZT5 or ZT13 recipients (Figure 4.6).  
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Figure 4.6 Reciprocal homing assays 
Spleen and bone marrow cells were collected from mice at ZT5 and ZT13 time points as 
donor cells. After incubation in CFSE (green) or Cell tracker deep red (red), donor cells were 
mixed and injected into ZT5 and ZT13 recipients. One hour later, blood was harvested and 
analyzed by flow cytometry. 
 
The data showed that ZT13 donor cells in a ZT13 recipients’ microenvironment 
exhibited the lowest number of donor cells in the circulation, indicating that highest 
homing had occurred in this combination, while ZT5 donor cells in ZT5 recipients 
showed the lowest homing capacity. The homing of ZT13 to ZT5 and ZT5 to ZT13 
groups were at intermediate levels, indicating that both the microenvironment and the 
leukocyte contribute to rhythmic leukocyte exit from the circulation (Figure 4.7). 
 
Figure 4.7 Reciprocal homing assays: leukocyte subsets 
ZT5 and ZT13 donor cells were mixed and labeled differently and injected into ZT5 and ZT13 
recipients. Donor cell numbers were normalized to ‘5 to 5’ (ZT5 donor cells transferred to 
ZT5 recipients). ZT13 donor cells to ZT13 recipients showed the fewest cells left in the 
circulation. n=21-24, one-way ANOVA followed by Tukey’s multiple comparison test. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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4.2. Tissue-specific oscillations in adhesion 
molecules expressed on endothelial cells 
contribute to the recruitment process 
 
 
4.2.1. Expression of endothelial adhesion 
molecules in various organ is oscillatory 
 
The endothelium is one of the major cell types that governs leukocyte migration. We 
therefore assessed which molecules expressed by these cells contributed to rhythmic 
leukocyte migration. We performed time course analyses of surface protein expression 
levels of eight key adhesion molecules expressed by endothelial cells, known to be 
important in leukocyte migration, using imaging-based approaches.  
We found expressions and oscillations of adhesion molecules on endothelial cells vary 
between organs, with some molecules being expressed at constant levels 
(represented by purple squares), other molecules’ expression levels fluctuated during 
24 hours (represented by red squares), while some were not expressed (represented 
by grey squares). Combining the results together, we detected the existence of a 
rhythmic tissue-specific molecular signature in the expression of pro-migratory factors. 
ICAM-1, ICAM-2, VCAM-1 and P-selectin were the most widely expressed adhesion 
molecules on the endothelial cells (Figure 4.8).  
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Figure 4.8 Expression of adhesion molecules in endothelial cells of various organs 
Expression of adhesion molecules on endothelial cells was measured by an image-based 
approach. Red squares represent higher expression levels than isotype controls and with a 
daily oscillation. Purple squares represent higher expression levels than isotype controls but 
without an oscillation. Grey squares represent expression levels equal to or lower than 
isotype control. n=3-6 with 6 time points measured each, one-way ANOVA. 
 
 
4.2.2. Blocking endothelial cells adhesion 
molecules abolishes rhythmic recruitment 
 
We next tested the involvement of specific molecules in the recruitment process 
focusing on a rhythmic microenvironment. We performed antibody blocking 
approaches together with adoptive transfer experiments. Blocking antibodies were 
injected into two groups of mice at ZT22 and ZT10, two hours before the transfer of 
donor cells. Donor cells from ZT1 donor mice were harvested and incubated with CFSE 
and injected into the two groups of mice simultaneously. One hour after the injection 
of donor cells, blood was harvested and analyzed by flow cytometry (Figure 4.9). Donor 
cell numbers were presented as percentage of injected donor cells, leukocyte subsets 
number were presented as percentage of injected leukocyte subsets, since the 
leukocyte subset number injected were not exactly the same for every experiment. 
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Figure 4.9 Antibody blocking in combination with adoptive transfer experiments 
Recipient mice were treated with blocking antibodies two hours before the injection of donor 
cells. Spleen and bone marrow cells were collected from donor mice at the ZT1 time point. 
After incubation in CFSE, donor cells were injected into ZT0 and ZT12 recipients. One hour 
later, blood was harvest from ZT1 and ZT13 recipients. 
 
 
We previously showed that the ZT13 microenvironment was more permissive for donor 
cells to leave the circulation. However, after antibody injection, the recruitment 
difference between ZT1 and ZT13 recipients was abolished for some leukocyte 
subsets. Our data suggest that the VCAM-1 antibody abolished recruitment rhythmicity 
of the total injected cells as well as leukocyte subsets. Blocking ICAM-1 diminished the 
recruitment rhythmicity of B cells, CD4 T cells, CD8 T cells, NK cells, non-inflammatory 
monocytes and eosinophils. In contrast, blocking ICAM-2, E-selectin, P-selectin had 
no effects on the rhythmic recruitment process (Figure 4.10). 
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Figure 4.10 Antibody blocking experiment with adoptive transfer experiments 
Blood of recipient mice treated with blocking antibodies or isotype control was analyzed by 
flow cytometry. Total donor numbers were presented as percentage of injected cells. Subset 
numbers were presented as percentage of injected leukocyte subsets. n=4-12, unpaired 
Student’s t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
 
Next, we confirmed the blocking effects of the anti-ICAM-1 antibody genetically using 
ICAM-1 knockout mice as recipients. In the knockout mice, recruitment rhythmicity 
between ZT1 and ZT13 recipients was abolished in total cells, neutrophils, B cells, CD4 
T cells, CD8 T cells, NK cells, NKT cells, non-inflammatory monocytes and eosinophils. 
However, the recruitment rhythmicity still existed for inflammatory monocytes (Figure 
4.11). 
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Figure 4.11 Adoptive transfer experiment with ICAM-1 knockout mice at ZT1 and ZT13 time 
points 
Blood of recipient mice was analyzed by flow cytometry. Total CFSE numbers were 
presented as percentage of injected cells. Subset numbers were presented as percentage 
of injected leukocyte subsets. n=6-8, unpaired Student’s t-test. *p<0.05 (manuscript in 
preparation). 
 
From the experiments above, we found both anti-VCAM-1 and anti-ICAM-1 
antibodies to exert blocking effects. Moreover, the blocking effects were stronger at 
the ZT13 time point, as a bigger fold change was found at this time point for total 
injected cells, as well as neutrophils, B cells, and NK cells for both VCAM-1 and 
ICAM-1 blockade. In addition, VCAM-1 blocking generated a higher effect at ZT13 
also for CD8 T cells, inflammatory monocytes, non-inflammatory monocytes, CD8 T 
cells, and NKT cells. A bigger blocking effect was found in CD4 T cells and 
eosinophils after ICAM-1 blockade (Figure 4.12).  
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Figure 4.12 Fold change of antibody blocking experiment 
The donor cell number left in blood was normalized to control mice. ZT1 groups were 
normalized to the ZT1 control group, and ZT13 groups were normalized to the ZT13 control 
group. n=7-12, one-way ANOVA followed by Dunnett comparison was performed to 
compare the control with treatment groups, #p<0.05, ##p<0.01, ###p<0.001, ####p, 
####p<0.0001; unpaired Student’s t-test was performed to compare the fold change between 
ZT1 and ZT13 groups after injection of antibodies. *p<0.05, **p<0.01, ***p<0.001 
(manuscript in preparation). 
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4.3. Leukocyte subset specific oscillations in 
adhesion molecules contribute to the recruitment 
process 
 
4.3.1. Leukocyte subsets have distinctly rhythmic 
expression patterns of adhesion molecules and 
chemokine receptors 
 
On the leukocyte side, we used flow cytometry to assess the expression levels of 
adhesion molecules and chemokine receptors of blood leukocytes at different time 
points. We found expression levels and oscillations of adhesion molecules and 
chemokine receptors on the surface of leukocytes to vary between subsets, with some 
molecules being expressed at constant levels (represented by purple squares), other 
molecules’ expression levels fluctuated during 24 hours (represented by red squares), 
while some were not expressed (represented by grey squares). Together, each 
leukocyte subset had its distinctive expression profile of these pro-migratory 
molecules. Adhesion molecules were widely expressed on leukocyte subsets, while 
chemokine receptors exhibited a more restricted expression profile (Figure 4.13).   
82 
 
 
Figure 4.13 Expression levels of adhesion molecules and chemokine receptors on leukocytes 
Adhesion molecules and chemokine receptor expression levels of blood leukocytes were 
measured by flow cytometry. Red squares represent molecules’ expression levels higher 
than isotype and being oscillatory. Purple squares represent molecules’ expression levels 
higher than isotype but without oscillation. Grey squares represent molecules’ expression 
levels equal to or lower than isotype control. n=3-6 with 4-6 time points measured each, one-
way ANOVA. 
 
 
4.3.2. Functional blocking experiments using 
antibodies or functional inhibitors inhibit the 
rhythmic recruitment process in a time-
dependent manner 
 
4.3.2.1. Adhesion molecules 
 
To investigate the critical molecules involved in the rhythmic recruitment process, we 
performed antibody blocking experiments against adhesion molecules. ZT0 and ZT12 
donor cells were transferred to ZT0 and ZT12 recipient mice that were treated with 
blocking antibodies two hours before.  One hour after donor cell injection, blood was 
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harvested from ZT1 and ZT13 recipients, and analyzed by flow cytometry. Donor cell 
numbers were presented as percentage of injected donor cells, and leukocyte subsets 
numbers were presented as percentage of injected leukocyte subsets (Figure 4.14). 
 
Figure 4.14 Antibody blocking with adoptive transfer experiment at one time point 
Recipient mice were treated with blocking antibodies two hours before injection of donor 
cells. Spleen and bone marrow cells were collected from mice at ZT0 and ZT12 time points 
as donor cells. After incubation in CFSE, donor cells were injected into ZT0 and ZT12 
recipients. One hour later, blood was harvested from ZT1 and ZT13 recipients. 
 
The results demonstrated that L-selectin, CD11a (LFA-1) and CD49d (VLA-4) are the 
molecules that mediated the homing of total donor cells or some leukocyte subsets as 
more donor cells were found in blood after antibody blockade. Blocking CD49d 
inhibited the homing of neutrophils, B cells, CD4 T cells, CD8 T cells, NK cells, and 
inflammatory monocytes. Blocking L-selectin decreased the emigration process of B 
cells, CD4 T cells, CD8 T cells, and non-inflammatory monocytes. CD11a blockade 
inhibited emigration of neutrophils.  A higher blockade effect at ZT13 was found in B 
cells after CD11a blocking, in inflammatory monocytes and eosinophils after CD49d 
blocking (Figure 4.15).  
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Figure 4.15 Antibody blocking with adoptive transfer experiment 
Blood of recipient mice was analyzed by flow cytometry. The donor cell number left in blood 
was normalized to control mice. ZT1 groups were normalized to ZT1 controls, and ZT13 
groups were normalized to ZT13 controls. n=3-12, one-way ANOVA followed by Dunnett 
comparison was performed to compare the control and treatment groups, #p<0.05, ##p<0.01, 
###p<0.001, ####p, ####p<0.0001; unpaired Student’s t-test was performed compare the fold 
change between ZT1 and ZT13 groups after injection of antibodies, *p<0.05, **p<0.01, 
***p<0.001 (manuscript in preparation).  
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4.3.2.2. Chemokine receptors 
 
 
We next investigated the function of chemokine receptors in rhythmic recruitment 
process. We first injected functional antagonists i.p. to ZT22 and ZT10 recipients. Two 
hours later, donor cells were injected into recipients. After one hour, blood was 
harvested and analyzed (Figure 4.16).  
 
Figure 4.16 Antibody blocking with adoptive transfer experiment 
Recipient mice were treated with antagonist two hours before injection of donor cells. Spleen 
and bone marrow cells were collected from mice at ZT1 time point as donor cells. After 
incubation in CFSE, donor cells were injected into ZT0 and ZT12 recipients. One hour later, 
blood was harvest from ZT1 and ZT13 recipients.  
 
Our data showed that an antagonist to CXCR4 can block rhythmic homing of total 
donor cells, neutrophils, CD4 T cells, CD8 T cells, NK cells, NKT cells, non-
inflammatory monocytes and eosinophils, but not including inflammatory monocytes, 
as for the latter the homing differences between ZT1 and ZT13 recipients still existed. 
This suggested that CXCR4 is critical for the homing of most but not all leukocyte 
subsets. A CXCR3 inhibitor affected the recruitment process of neutrophils, CD4 T 
cells, CD8 T cells, NK cells, NKT cells, inflammatory monocytes and eosinophils. A 
CCR1 inhibitor affected the migration of CD4 T cells, CD8 T cells, NK cells, 
inflammatory monocytes, and non-inflammatory monocytes. Blocking CCR2 affected 
rhythmic homing of neutrophils, B cells, CD4 T cells, CD8 T cells, NK cells, NKT cell, 
non-inflammatory monocytes and eosinophils. In contrast, the CXCR2 and CCR4 
inhibitors did not exert effects on the recruitment process of most subsets (Figure 4.17). 
Since the blocking effects of the CXCR3, CCR2 or CCR1 inhibitor were not as strong 
as CXCR4 inhibitor, we therefore focused on the CXCR4 inhibitor in subsequent 
studies.  
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Figure 4.17 Antagonist blocking with adoptive transfer experiment 
Blood of recipient mice which were treated with blocking antibodies or control reagents was 
analyzed by flow cytometry. Total CFSE numbers were presented as percentage of injected 
cells. Subset numbers were presented as percentage of injected leukocyte subsets. n=3-10, 
unpaired Student’s t-test was performed between ZT1 and ZT13 groups. *p<0.05, **p<0.01, 
****p<0.0001 (manuscript in preparation). 
 
These experiments demonstrated CXCR4 to be a critical factor in homing. Moreover, 
the blocking effects was much more obvious at ZT13 compared to ZT1, as a bigger 
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fold change was detected at this time point, indicating that a more active recruitment 
process occurred at night (Figure 4.18). 
 
Figure 4.18 Fold change of CXCR4 antagonist experiments 
The donor cell number left in blood was normalized to control mice. ZT1 groups were 
normalized to ZT1 controls, and ZT13 groups were normalized to ZT13 controls. n=3-6, one-
way ANOVA followed by Dunnett comparison was performed to compare the control and 
treatment groups, #p<0.05, ##p<0.01, ###p<0.001, ####p, ####p<0.0001; unpaired Student’s t-
test was performed to compare the fold change between ZT1 and ZT13 groups after CXCR4 
blockade. *p<0.05, **p<0.01(manuscript in preparation).  
 
 
4.4. The homing of leukocyte subsets to specific 
organs is time-of-day dependent 
 
Our data indicated that leukocyte leave the circulation in a time-dependent manner.  
We next investigated where the cells went. To address this, homing experiments were 
performed. Donor cells were collected from ZT5 and ZT13 recipients and incubated 
with CFSE. Then, donor cells were injected into ZT5 and ZT13 recipients. After one 
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hour, spleen, bone marrow, lymph nodes, lung and liver were harvested and measured 
by flow cytometry (Figure 4.19). 
 
Figure 4.19 Homing experiment to organs 
Spleen and bone marrow cells were collected from mice at ZT5 and ZT13 time points as 
donor cells. After incubation with CFSE, donor cells were injected into recipient at ZT5 and 
ZT13, respectively. One hour later, organs were harvested and analyzed by flow cytometry. 
 
Homed cells to organs exhibited an inverse trend to the cells left in blood with more 
cells having migrated to organs at ZT13 compared with ZT1(Figure 4.20). The homed 
donor cell numbers in lymph nodes were presented as absolute numbers, since the 
total lymph node numbers were reported to change over time (Druzd et al. 2017). For 
all other organs, the total cellularity was stable at the investigated time points, 
therefore, the homed donor cell numbers were represented as percentage of CD45+ 
cell numbers in this organ. The major recruited leukocyte populations to organs were 
tissue specific. In lymph nodes, CD4 T cells, CD8 T cells and B cells were the three 
major populations. In spleen, neutrophils, B cells and CD8 T cells were the three major 
populations. In bone marrow, neutrophils, B cells and inflammatory monocytes were 
the major populations. In liver, inflammatory monocytes, neutrophils and B cells, for 
lung, neutrophils, B cells and inflammatory monocytes were the three biggest 
populations (Figure 4.20).  
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Figure 4.20 Homing experiment to various organs 
Organs were harvested and analyzed by flow cytometry. The first column represents ZT5 
recipients, and the second one represents ZT13 recipients. Lymph node, n=11-14; spleen, 
n=24-25; Bone marrow, n=24-25; Liver, n=10; Lung, n=10, unpaired Student’s t-test. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
 
 
4.5. Time-dependent leukocyte migration of organs 
is adhesion molecule- and leukocyte subset-
specific 
 
To investigate the specific effects of pro-migratory molecules on rhythmic homing, we 
performed antibody or functional inhibitor blocking in combination with homing 
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experiments using ZT13 mice as recipients. To identify the precise location of cells, 
namely whether donor cells in the organ were inside or outside the vasculature, we 
injected an anti-CD45 antibody (clone I3/2.3), five minutes before perfusion of the 
recipient mice (Figure 4.21). 
 
Figure 4.21 Antibody or functional inhibitor blocking experiments 
Recipient mice were treated with blocking antibodies or functional inhibitors two hours before 
injection of donor cells. Spleen and bone marrow cells were collected from mice at ZT1 time 
point as donor cells. After incubation in CFSE, donor cells were injected into ZT12 recipients.  
After 55 minutes, CD45 antibody was injected i.v. into recipient mice. Five minutes later, 
mice were perfused and organs were harvested and analyzed by flow cytometry.   
 
We performed a perfusion to remove free-flowing cells in the circulation. Using two 
different anti-CD45 antibody clones, we were able to identify whether donor cells were 
still inside or outside the vasculature. If donor cells were positive for the injected anti-
CD45 clone, they were located in the vasculature. In liver and lung, more than 97% of 
donor cells were thus shown to be inside the vasculature. In contrast, in bone marrow, 
spleen and lymph node, only 3-9% of donor cells were found inside the vessel, as most 
of the donor cells migrated already into the tissues and were negative for the i.v. 
injected anti-CD45 antibody (Figure 4.22).  
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Figure 4.22 Flow cytometry of organs in homing experiment after i.v. injection of CD45 
Injected anti-CD45 (clone I3/2.3) identified cells’ firm attachment to the vasculature. Ex vivo 
staining of CD45 (clone 30-F11) stained for all the CD45+ cells. The CD45 injected positive 
population thus represents the attached donor cells, while the CD45 injected negative 
population represents cells that had migrated into the tissues. In bone marrow, spleen and 
lymph node, most of the donor cells had migrated into the tissues, while in liver and lung, 
the majority of the donor cells were attached to the vasculature (manuscript in preparation). 
 
 
4.5.1. Migration of donor cells to the lung 
 
In order to identify the blocking effect of each inhibitor and which leukocyte subset they 
targeted, we compared donor cell numbers in different antibody treatment groups with 
control groups. For total donor cells, blockade of VCAM-1, ICAM-1, CXCR4, CD11a 
showed decreased donor cell numbers in the lung. In contrast, anti-L-selectin did not 
inhibit the homing of donor cells. The blocking effects of these inhibitors was mainly 
due to an effect on B cells and inflammatory monocytes (Ly6Chigh), since these were 
the two biggest populations that migrated to the lung (Figure 4.20). Blocking VCAM-1, 
ICAM-1, CXCR4, CD49d decreased CD4 T cell numbers. Anti-VCAM-1 and anti-ICAM-
92 
 
1 antibodies showed a blocking effect for CD8 T cell migration. However, the biggest 
population, neutrophils, was not affected by any of these functional blockers (Figure 
4.23). 
 
Figure 4.23 Recruited donor cells in the lung in antibody blocking with homing experiment 
Lung was harvested from ZT13 recipients after injection of antibodies or PBS and given 
donor cells. Recruited donor cells were compared with control groups. n=4-8, unpaired 
Student’s t-test. *p<0.05, **p<0.01, ***p<0.001 (manuscript in preparation). 
 
Since more than 97% of donor cells attached to the vessel in the lung (Figure 4.22), 
the change of leukocyte number was mostly due to effects inside the vasculature 
(Figure 4.24). 
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Figure 4.24 Recruited donor cells inside the lung vasculature  
Lung was harvested from ZT13 recipients after injection of antibodies or PBS and donor 
cells. Recruited donor cells were compared with control groups. ‘In’ means cells in the 
vasculature.  n=4-8, unpaired Student’s t-test. *p<0.05, **p<0.01, ***p<0.001 (manuscript in 
preparation). 
 
 
4.5.2. Migration of donor cells to the liver 
 
Donor cells recruited to the liver were decreased by VCAM-1, ICAM-1 or CXCR4 
blockade. This effect was mainly due to an effect on neutrophils, B cells and 
inflammatory monocytes (Ly6Chigh), and only slightly due to CD4 T cells and CD8 T 
cells, as the latter represent only small populations in the liver. Blocking VCAM-1 or 
ICAM-1 decreased numbers of inflammatory monocytes and CD4 T cells. VCAM-1 
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but not ICAM-1 was involved in neutrophil homing to liver, while homing for B cells 
and CD8 T cells were ICAM-1 dependent. Targeting CXCR4 inhibited the 
recruitment process of inflammatory monocytes, CD4 T cells and probably CD8 T 
cells. While blocking L-selectin showed a trend to decrease the numbers of 
inflammatory monocytes, it increased the numbers of neutrophils and B cells in the 
vasculature of the liver. Anti-CD49d antibody also showed an inverse effect for 
different leukocyte subsets. While blocking CD49d decreased the number homed 
inflammatory monocytes, it increased the number of B cells which may be recruited 
to the liver in an unspecific manner. CD11a did not play any function role in the liver 
recruitment process for total leukocyte numbers as well as for the individual 
leukocyte subsets (Figure 4.25).  
 
Figure 4.25 Recruited donor cells in the liver in antibody blocking with homing experiment 
Liver was harvested from ZT13 recipients after injection of antibodies or PBS and donor 
cells. Recruited donor cells were compared with control groups. n=4-8, unpaired Student’s 
t-test. *p<0.05, **p<0.01, ***p<0.001 (manuscript in preparation). 
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In the liver, more than 97% donor cells remained in the vasculature. Therefore, the 
effects we saw above was mostly due to the cell number change in the vasculature 
(Figure 4.26). 
 
Figure 4.26 Recruited donor cells inside the liver vasculature  
Liver was harvested from ZT13 recipients with injection of antibodies or PBS and donor cells. 
Recruited donor cells were compared with control groups. ‘In’ means cells in the vasculature. 
n=4-8, unpaired Student’s t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript 
in preparation). 
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4.5.3. Migration of donor cells to the lymph node 
 
Total donor cell numbers in the lymph node were strongly decreased by blocking 
ICAM-1, CD11a or L-selectin. This effect was found for the lymphocyte subsets, 
including B cell, CD4 T cells, CD8 T cells, neutrophils as well as inflammatory 
monocytes. In addition, neutrophils, B cells and inflammatory monocytes were 
decreased by the CXCR4 antagonist, while CD8 T cell numbers increased.  
Neutrophils could also be blocked with the anti-CD49d antibody. (Figure 4.27). 
 
Figure 4.27 Recruited donor cells in the lymph nodes in antibody blocking with homing 
experiment 
Lymph nodes were harvested from ZT13 recipients after injection of antibodies or PBS and 
donor cells. Recruited donor cells were compared with control groups. n=4-8, unpaired 
Student’s t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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In lymph nodes, most of the adoptive transferred cells had migrated into the organ, 
with less than 5% being adherent to the vascular endothelium (Figure 4.22). Donor 
cells were divided into two populations, cells inside or outside the vessel. The results 
showed that both the cells that had migrated into the tissues or were attached to the 
vessels were greatly decreased after injection of blocking antibody against ICAM-1, 
CD11a or L-selectin. The transmigrated donor cell numbers of major populations, CD4 
T cells, CD8 T cells, and B cells, were greatly decreased by ICAM-1, CD11a or L-
selectin blockade. The intravascular numbers of B cells decreased after ICAM-1 or L-
selectin blockade. CD4 T cells showed decreased numbers in the vessel after L-
selectin blockade. Neutrophils and monocytes were very minor populations in lymph 
nodes. Neutrophil numbers were decreased by blocking CXCR4, CD49d, CD11a or L-
selectin, and intravascular neutrophil numbers were decreased by targeting CD49d or 
L-selectin. Monocyte migration into the tissues of lymph nodes was inhibited by ICAM-
1 or L-selectin blockade, while the cells adherent to the vessel were affected by 
blocking VCAM-1, ICAM-1 CXCR4, CD11a, CD49d or L-selectin (Figure 4.28). 
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Figure 4.28 Recruited donor cells inside or outside the lymph node vasculature  
Lymph nodes were harvested from ZT13 recipients after injection of antibodies or PBS and 
donor cells. ‘Ex’ refers to as cells outside the vasculature, while ‘In’ refers to cells inside the 
vasculature. n=4-8, unpaired Student’s t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
(manuscript in preparation). 
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4.5.4. Migration of donor cells to the spleen 
 
Migration of total injected donor cells to the spleen was inhibited by blocking L-selectin. 
Anti-L-selectin antibody showed a wide blocking effect for neutrophils, B cells, CD4 T 
cells and CD8 T cells. Anti-ICAM-1 antibody targeted B cells and inflammatory 
monocytes. Blocking CXCR4 or CD49d inhibited CD4 T cells homing to spleen(Figure 
4.29). 
 
Figure 4.29 Recruited donor cells in the spleen in antibody blocking with homing experiment 
Spleens were harvested from ZT13 recipients after injection of antibodies or PBS and donor 
cells. Recruited donor cells were compared with control groups. n=4-8, unpaired Student’s 
t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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Donor cells that had migrated to the spleen were mostly located outside the 
vasculature (more than 90%) (Figure 4.22). L-selectin blockade decreased the total 
number of migrated leukocytes into the spleen. The biggest migratory population in 
the spleen was neutrophils, which were affected by CD49d and L-selectin blockade, 
while more neutrophils were attached to the vessel endothelium after blockade of 
CXCR4. The second major population migrated to spleen was B cells. Migration of 
B cells into the spleen was decreased by ICAM-1, CD11a or L-selectin blockade, but 
increased by VCAM-1 blocking. Blocking CD11a or CD49d increased the number of 
intravascular B cells. CD4 T cells were inhibited from homing to spleen by CXCR4, 
CD49d or L-selectin blockade, while intravascular CD4 T cells numbers were 
increased by CD11a blockade. Extravascular CD8 T cells numbers were increased 
by VCAM-1 blockade, but decreased by L-selectin blockade. Homing of inflammatory 
monocytes to spleen was inhibited by ICAM-1 blockade (Figure 4.30). 
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Figure 4.30 Recruited donor cells inside or outside the spleen vasculature 
Spleens were harvested from ZT13 recipients after injection of antibodies or PBS and donor 
cells. Recruited donor cells were compared with control groups. ‘Ex’ refers to as cells outside 
the vasculature, while ‘In’ refers to cells inside the vasculature. n=4-8, unpaired Student’s t-
test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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4.5.5. Migration of donor cells to the bone marrow 
 
For the bone marrow, the number of total recruited cells could be inhibited by blocking 
VCAM-1, ICAM-1, CXCR4, CD49d, but the strongest blocking effect was found after 
CXCR4 antagonist injection. Both VCAM-1 and ICAM-1 targeted B cells and CD8 T 
cells, but only VCAM-1 had an impact on CD4 T cell migration to this tissue. L-selectin 
blocking decreased neutrophil migration, but increased CD4 T cells migration. Anti-
CD49d antibody affected B cells, CD4 T cells and CD8 T cells. The CXCR4 antagonist 
had a strong effect on B cells, neutrophils, CD4 T cells, CD8 T cells, but not 
inflammatory monocytes (Figure 4.31). 
 
Figure 4.31 Recruited donor cells in the bone marrow in antibody blocking with homing 
experiment 
Bone marrow was harvested from ZT13 recipients after injection of antibodies or PBS and 
donor cells. Recruited donor cells were compared with control groups. n=4-8, unpaired 
Student’s t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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CXCR4 inhibition decreased the number of migrated cells into the bone marrow, except 
for inflammatory monocytes. Neutrophil recruitment to bone marrow was strongly 
decreased by CXCR4 blockade, while a lot of neutrophils were blocked at the 
transmigration stage and remained at the stage of adhesion, therefore the 
intravascular neutrophil number increased. Besides CXCR4, neutrophils homing to 
bone marrow was inhibited by ICAM-1 or L-selectin blockade. B cells were greatly 
affected by VCAM-1, ICAM-1, CXCR4 or CD49d interference. Blocking CXCR4 
increased intravascular B cells, while blocking VCAM-1 or CD49d decreased the 
numbers of intravascular B cells. Inflammatory monocytes migration in to the bone 
marrow tissue was inhibited by ICAM-1, while increased by CD11a blockade. 
Inflammatory monocytes remained in the vasculature increased after CXCR4 
blockade. CD8 T cells migration could be decreased by VCAM-1, ICAM-1, CXCR4 or 
L-selectin blockade. CD4 T cells migration into the bone marrow could be inhibited by 
VCAM-1 or CXCR4 blockade, while CD4 T cells numbers were increased in bone 
marrow tissue and vessel after L-selectin blockade, and increased only in the vessel 
after ICAM-1 blockade (Figure 4.32). 
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Figure 4.32 Recruited donor cells inside or outside the bone marrow vasculature  
Bone marrow was harvested from ZT13 recipients after injection of antibodies or PBS and 
donor cells. Recruited donor cells were compared with control groups. ‘Ex’ refers to as cells 
outside the vasculature, while ‘In’ refers to cells inside the vasculature. n=4-8, unpaired 
Student’s t-test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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To summarize the results, two matrixes were created as below, showing the blocking 
effect of each blocker for every organ (Figure 4.33). The figure B is a different 
representation of figure A.  
 
Figure 4.33 Matrix of molecular dependency of leukocyte subtype homing to specific organs 
Donor cells in each organ after antibody or inhibitor blocking were compared with the control 
group. Blue squares: donor cell number lower than the isotype or PBS control, red square: 
donor cells number higher than the control. (A) Donor cell numbers changes were presented 
for each organ. (B) Donor cells number changes were presented according to the treatment. 
For each subset, either the intravascular or the extravascular numbers were shown. For lung 
and liver, the intravascular subsets numbers were shown; for spleen, lymph node and bone 
marrow, the extravascular subsets numbers were shown. n=4-8, one-way ANOVA. 
(manuscript in preparation). 
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4.6. Control of rhythmic leukocyte migration by the 
circadian clock 
 
4.6.1. Circadian genes oscillate in leukocyte 
subsets 
 
Clock genes control circadian oscillations. The core clock genes are Bmal1 (also 
known as Arntl) and Clock which are negatively regulated by the clock genes Per1, 
Per2, Cry1 and REV-ERBα (encoded by Nr1d1). We analyzed the mRNA levels of 
these important clock genes from isolated monocytes and neutrophils from bone 
marrow, and isolated B cells from spleen. We found some clock genes to oscillate at 
the mRNA level over 24 hours (Figure 4.34). 
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Figure 4.34 Q-PCR analysis of circadian genes in isolated cells 
Relative mRNA expression levels of Bmal1, Clock, Cry1, Per1, Per2, and Nr1d1 analyzed 
from isolated monocytes (A), neutrophils (B) and B cells (C) over 24 hours. n=3, one-way 
ANOVA. *p<0.05, **p<0.01, ****p<0.0001 (manuscript in preparation). 
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4.6.2. Leukocyte clocks and rhythmic migration 
 
In the next step, we assessed whether the different recruitment capacity of donor cells 
at different times was controlled by the circadian clock. Therefore, we performed 
adoptive transfer experiments using donor cells with ablation of the circadian gene 
Bmal1 (Figure 4.35 and Figure 4.36). 
 
Figure 4.35 Adoptive transfer with Bmal1 KO donor cells 
Spleen and bone marrow cells were collected from mice at ZT1 and Zt13 time point as donor 
cells. After incubation in CFSE, donor cells were injected into ZT6 recipients. After 55 
minutes, CD45 antibody was injected i.v. to recipient mice. Five minutes later, mice were 
perfused and spleen was harvested and analyzed by flow cytometry. 
 
We performed experiments using Lyz2-cre and CD19-cre Bmal1 knockout mice as 
donors. While Lyz2-cre Bmal1 targets Bmal1 expression in myeloid cells, such as 
neutrophils and monocytes, the CD19-cre Bmal1 specifically targets B cell Bmal1 
expression. The difference of recruitment capacity between ZT1 and ZT13 donor cells 
in spleen was abolished in neutrophils and inflammatory monocytes when using Lyz2-
cre Bmal1flox/flox donor cells, and was lost in B cells when using CD19-cre Bmal1flox/flox  
donor cells, indicating that the recruitment capacity of cells over the day was controlled 
by Bmal1 and the circadian clock (Figure 4.36). 
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Figure 4.36 Donor cells in spleen with Bmal1 KO or control mice as donors  
Spleens were harvested from ZT6 recipients and analyzed by flow cytometry. Recruited 
donor cells were compared with control groups. ‘Ex’: cells outside the vasculature, ‘In’: cells 
inside the vasculature.   n=5-6, t-test. *p<0.05, **p<0.01 (manuscript in preparation). 
 
We performed flow cytometry analyses to compare the expression levels of adhesion 
molecules on the CD19-cre Bmal1flox/flox blood cells or Lyz-cre Bmal1flox/flox blood cells 
with cells from their littermate controls. Bmal1 knockout B cells exhibited lower 
expression levels of CD11a, CD49d and CXCR5, all critical molecules for B cell 
migration (Figure 4.37 A). Bmal1 knockout neutrophils exhibited lower expression 
level of PSGL-1 (Figure 4.37 B). 
 
Figure 4.37 Expression levels of adhesion molecules and chemokine receptors on B cells 
(A) Expression levels of CD11a, CD49d and CXCR5 were measured by flow cytometry on 
the surface of blood B cells of CD19-cre Bmal1 knockout mice and their controls. n=8, 
unpaired Student’s t-test. (B) Expression level of PSGL-1 on the surface of blood neutrophils 
of Lyz-cre Bmal1 knockout mice and their controls. n=4-5, unpaired Student’s t-test.  *p<0.05 
(manuscript in preparation). 
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4.6.3. Endothelial cell clocks and rhythmic 
migration 
 
We investigated whether not only the leukocytes but also the microenvironment was 
directly controlled by circadian genes. We therefore performed adoptive transfer 
experiments using Cdh5-cre/ERT2 Bmal1flox/flox and control mice as recipients 
(Figure 4.38), thus deleting Bmal1 in endothelial cells. To induce Cre expression, 
mice were treated with tamoxifen i.p. for five consecutive days. 
 
Figure 4.38 Adoptive transfer experiment with Bmal1 KO recipients 
Spleen and bone marrow cells were collected from mice at the ZT1 time point as donor cells. 
After incubation with CFSE, donor cells were injected into ZT1 and ZT13 recipients. One 
hour later, was blood harvested and analyzed by flow cytometry. 
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The results in control mice confirmed the previous results that ZT13 recipients had 
fewer total donor cells left in blood as well as specific leukocyte subsets (Figure 4.3). 
However, in Cdh5-cre/ERT2 Bmal1 knockout recipients, this difference was 
abolished (Figure 4.39). 
 
Figure 4.39 Adoptive transfer experiment with endothelial cell Bmal1 KO 
Blood was harvested from ZT1 and ZT13 Cdh5-cre/ERT2 Bmal1 knockout and control mice 
and analyzed by flow cytometry. Donor cells in blood were compared between ZT1 and ZT 
13 groups. n=3-5, unpaired Student’s t-test.  *p<0.05, **p<0.01 (manuscript in preparation). 
 
 
4.7. Human blood oscillation 
 
We further investigated the circadian rhythms in human capillary blood by finger 
puncture, and checked the leukocyte subsets number at several time points. Our 
data showed human blood leukocyte number peaked at night and troughed during 
the day (Figure 4.40 ), which is inverse to murine blood (Figure 4.1).  
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Figure 4.40 Human blood flow cytometry 
Human capillary blood was measured at five human time points by flow cytometry. (A) 
Human blood leukocyte number. (B) CXCR4 expression on leukocyte subsets. n=8, 
repeated measures one-way ANOVA.   *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
(manuscript in preparation). 
 
 
We measured the CXCR4 expression levels on the surface of human blood 
leukocyte subsets as well as murine blood leukocytes by flow cytometry. Almost all 
human blood leukocytes subsets showed oscillatory expression of CXCR4 with a 
peak during the day and a trough at night (Figure 4.41 A). CXCR4 expression also 
oscillated on murine blood cells, but at an inverse trend to humans (Figure 4.41 B). 
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Figure 4.41 CXCR4 expression on human leukocytes and murine leukocytes 
(A) CXCR4 expression on human blood leukocyte subsets. n=8, repeated measures one-
way ANOVA.   (B) CXCR4 expression on murine blood leucocytes. n=3, one-way ANOVA. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 (manuscript in preparation). 
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5. Discussion 
 
5.1. Oscillation and recruitment process of murine 
blood leukocytes 
 
We describe here a circadian rhythmicity in the trafficking behavior of leukocyte 
subsets in murine blood, including neutrophils, B cells, CD4 T cells, CD8 T cells, 
inflammatory monocytes, non-inflammatory monocytes, NK cells, NKT cells and 
eosinophils (Figure 4.1). Although distinct leukocyte subset serves specific immune 
functions, they all showed similar oscillation patterns exhibiting a peak in their number 
in blood during the day when mice are in the behavioral resting phase, and a trough at 
the onset of darkness. In contrast to nocturnal rodents, humans are diurnal and 
generally exhibit inverse circadian rhythms in peripheral blood numbers compared to 
mice (Born et al. 1997). This close relationship of circadian rhythms of blood cell 
numbers with the change in light suggests that leukocytes are synchronized by the 
central clock to optimize their immune function in accordance with environmental 
changes.  
The recruitment of leukocytes out of the blood is one of the reasons for the dramatic 
leukocyte number change seen over 24 hours. Our data show that more donor cells 
leave the circulation at night than during the day (Figure 4.3). The leukocytes that have 
left the blood were shown to be either still attached to the inside of the vessel wall (as 
seen for the lung and the liver) or to have transmigrated across the endothelial barrier 
into the underlying tissue (as seen for spleen, bone marrow and lymph node) (Figure 
4.22). Since the migration of leukocytes occurs in multiple steps governed by their 
interactions with endothelial cells, we wanted to investigate which of the cell types were 
essential for a rhythmic recruitment process. A recent study using a humanized mouse 
model found that human cells in mouse blood still keep human blood cell rhythmicity 
peaking at the night phase, which is inverse to mouse blood cells, suggesting that the 
leukocyte intrinsic clock is critical even in an out-of-phase environment (Zhao et al. 
2017). However, in our assay, through performing adoptive transfer experiments by 
changing the donor cells and microenvironment, respectively, we could show that both 
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the leukocytes and the microenvironment were essential for the rhythmic recruitment 
process (Figure 4.3,Figure 4.5).  
We further confirmed our results through reciprocal adoptive transfer experiments. We 
found that ZT13 donor cells injected into ZT13 recipients showed the highest 
emigration capacity (Figure 4.7). Since the migration of leukocytes occurs by the 
interactions of pro-migratory molecules on leukocytes and endothelium, this finding 
indicated that some pro-migratory molecules may have higher expression at ZT13. 
 
5.2. A zip code for the circadian leukocyte 
recruitment process 
 
We screened the expression levels of pro-migratory molecules including adhesion 
molecules and chemokine receptors at various time points. We found their expression 
levels were distinct across the day on the endothelium of organs and also on the 
surface of leukocyte subsets (Figure 4.8, Figure 4.13). Previous research in the lab 
had found that hematopoietic stem and progenitor cells were recruited to the bone 
marrow by rhythmic P-selectin, E-selectin and VCAM-1 expression, while monocytes 
and neutrophils to skeletal muscle depended on ICAM-1 expression, demonstrating 
that cells migrate to distinct places due to a different combination of molecules 
(Scheiermann et al. 2012).  
Interestingly, the expression of pro-migratory molecules is not constant, instead they 
are oscillatory with a cell-type and organ-specific signature (Druzd et al. 2017). In 
humans, blood T cells have higher expression of L-selectin, CD49d, CX3CR1, CXCR1 
and CXCR4 in the morning (Dimitrov et al. 2009). These time-of-day differences of the 
expression of pro-migratory molecules drive leukocytes to leave blood and migrate into 
organs at different times, which could explain that more homing of leukocytes occurs 
at night in mice.  
We investigated the role of pro-migratory molecules in rhythmic homing by functional 
blocking these molecules, including VCAM-1, ICAM-1, L-selectin, CD11a, CD49d and 
CXCR4, and compared the number of injected cells left in blood. In control 
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experiments, we noticed that donor cell numbers were lower at ZT13 compared to ZT1, 
indicating that a recruitment/clearing process from blood occurred more prominently at 
night (Figure 4.10). However, with the injection of functional blockers, this homing 
rhythmicity was abolished for VCAM-1, ICAM-1, CXCR4 and CD49d (Figure 
4.10,Figure 4.15,Figure 4.17), suggesting that these molecules are essential for a 
rhythmic homing process. Interestingly, the blocking effects were not seen for every 
leukocyte subset, suggesting a leukocyte-specific blocking effect. 
On the endothelium, VCAM-1 and ICAM-1 are two widely expressed adhesion 
molecules that have essential roles for leukocyte migration (Ley et al. 2007). Antibody 
treatment against VCAM-1 abolished the homing rhythmicity of all investigated 
leukocyte subsets, while blocking ICAM-1 mainly targeted lymphocytes, non-
inflammatory monocytes, and eosinophils (Figure 4.10).  
On the leukocyte side, L-selectin is a molecule important in the initiation of the 
adhesion cascade (Marelli-Berg et al. 2008). We found the expression of L-selectin to 
be oscillatory on the surface of many leukocyte subsets (Figure 4.13). Compared with 
the control group of the donor cells left in blood, blocking L-selectin inhibited the 
migration of neutrophils, B cells, CD4 T cells, CD8 T cells, non-inflammatory 
monocytes and eosinophils in the evening time point, but not NK cells, and 
inflammatory monocytes (Figure 4.15).  
VLA-4 (CD49d) and LFA-1 (CD11a), two very important integrins in the adhesion 
cascade also have oscillatory expression levels on leukocyte subsets. Blocking VLA-4 
affected the migration of neutrophils, B cells, CD4 T cells, CD8 T cells, NK cells, 
inflammatory monocytes. For NK cells and B cells, the blocking effects after VLA-4 
blockade were found both in the day and evening time points, while more subsets such 
as neutrophils, CD4 T cells, CD8 T cells and inflammatory monocytes were inhibited 
in the evening time point.  Blocking LFA-1 decreased the emigration process of 
neutrophils at night, based on the remaining donor cells numbers in blood (Figure 
4.15).  
Among the chemokine receptors, CXCR4 plays an important role in the homing 
process. Some studies demonstrated that an CXCR4 antagonist can inhibit the 
neutrophil recruitment process (Furze and Rankin 2008). We found that CXCR4 was 
not only important for neutrophils, but that it is also crucial for the recruitment process 
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of other leukocyte, including B cells, CD4 T cells, CD8 T cells, NK cells, non-
inflammatory monocytes, and eosinophils, but interestingly not for inflammatory 
monocyte based on the cells left in blood (Figure 4.17). 
Of importance, blocking ICAM-1, VCAM-1, CXCR4 and CD49d at night (ZT13) 
generated a much stronger effect than during the day (ZT1), indicating more leukocyte 
homing occurs at night than during the day, a process governed by these pro-migratory 
molecules.   
In conclusion, the differences in the molecular signature of circadian expression of 
endothelial cell adhesion molecules and chemokines in tissues are responsible for the 
diurnal preference in the recruitment process.  
 
5.3. Specific migration to organs 
 
Leukocytes are transported by the blood across the body. By using spleen and bone 
marrow as donor cells, we found that specific donor cell subsets preferentially migrated 
to select organs. In the lymph nodes, most of the migrated donor cells were 
lymphocytes. In the spleen, the three major recruited populations were neutrophils, B 
cells, and CD8 T cells, while in bone marrow, they were neutrophils, B cells and 
inflammatory monocytes. Neutrophils were recruited at higher numbers than any other 
leukocyte subset to the lung, followed by B cells and inflammatory monocytes. In liver, 
it was inflammatory monocytes that made up the biggest population, followed by 
neutrophils and B cells (Figure 4.20). 
Interestingly, the recruited cells were quite differently located in various organs. In lung 
and liver, more than 97% of donor cells were found in the vessel after perfusion, while 
in bone marrow, spleen and lymph node, more than 90% of donor cells had migrated 
into the tissues (Figure 4.22), suggesting that the unique morphology of each organ 
can determine the spatial localization of the donor cells.  
Through the combination of blocking and homing experiments for each major organ 
(Figure 4.12) we found that blocking one molecule could cause distinctive effects for 
specific leukocyte subsets in specific organs. For example, CXCR4 is an important 
118 
 
chemokine receptor for leukocyte homing to the bone marrow (Casanova-Acebes et 
al. 2013). The CXCR4 antagonist AMD3100 blocked neutrophil, B cell, CD4 T cell and 
CD8 T cell homing to bone marrow (Figure 4.31). But AMD3100 did not block the same 
population in other organs. It blocked neutrophils and B cells homing to lymph nodes 
(Figure 4.27), and only affected CD4 T cells homing to spleen (Figure 4.29), suggesting 
CXCR4 to specifically target some leukocytes subsets in the recruitment process to 
specific organs.  
Therefore, the discussion of the functional blocking effects of each molecule will be 
addressed in each organ. The lung contains a big marginated pool of neutrophils. 
Neutrophils are retained in the lung capillaries and temporarily sequestered from the 
circulating blood (Kuebler and Goetz 2002). In accordance with a previous study (Doyle 
et al. 1997), our data showed that blocking homing could not decrease the numbers of 
injected donor neutrophils in the lung, suggesting neutrophil margination in the lung is 
mainly due to the morphology of neutrophils, and that it is not an adhesion molecule 
dependent process, at least during steady state. However, other leukocyte subsets 
were influenced by blocking pro-migratory molecules. Consistent with a previous study 
(Lehmann et al. 2003), deceased number of lymphocytes were found in the lung after 
VLA-4/VCAM-1 blocking and LFA-1/ICAM-1 blocking.  Our data showed inflammatory 
monocytes could also be inhibited by LFA-1/ICAM-1 blocking. And the CXCR4 
antagonist affected B cells, CD4 T cells, and inflammatory monocytes. Consistent with 
previous studies (Doyle et al. 1997), none of these cells’ migration to the lung was 
found to be L-selectin dependent (Figure 4.23,Figure 4.24). 
The liver is another major site for neutrophil recruitment, this process was only affected 
by VCAM-1 of all the molecules we investigated (Figure 4.25), and may also be CD44 
dependent (Lee and Kubes 2008), a molecule we did not test functionally. In line with 
a previous study (Lee and Kubes 2008), LFA-1 was not required for liver homing, 
because none of the cells we invested were blocked by an anti-LFA-1 antibody. 
However, ICAM-1 blockade inhibited homing of lymphocytes, which confirms a 
previous study (John and Crispe 2004), as well as inflammatory monocytes. Besides 
ICAM-1, CD4 T cells and inflammatory monocytes adhesion to liver endothelium and 
migration were mediated by VCAM-1. Although CXCR4 was essential for neutrophil 
homing to bone marrow, it didn’t mediate neutrophil but CD4 T cells and inflammatory 
monocytes homing to liver (Figure 4.25,Figure 4.26). On the contrary, CD49d blocking 
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elevated the number of recruited B cells in the liver, as well as L-selectin blocking. We 
also observed an increase of neutrophils after L-selectin inhibition. The most likely 
explanation for this is that these cells were prevented from recruitment to their regular 
homing sites because of antibody blockade and therefore transported to the liver with 
the blood flow where they became adherent to liver sinusoidal endothelial cells. 
The major population homing to lymph nodes are CD4 T cells, CD8 T cells and B cells. 
Very small numbers of donor neutrophils and monocytes were found in lymph nodes 
(Figure 4.22). The migration to lymph nodes was greatly dependent on L-selectin 
(Arbones et al. 1994), since anti-L-selectin antibody blocked recruitment of every 
leukocyte subset we investigated to lymph node, both into the tissue and attached to 
the endothelium. This indicated L-selectin to be an indispensable molecule to initiate 
interactions between leukocytes and HEV. For the firm adhesion steps, LFA-1/ICAM-
1 is an essential pair of adhesion molecules for lymphocytes (Lehmann et al. 2003), 
and our data showed blocking LFA-1 or ICAM-1 decreased the homing of lymphocytes. 
CXCR4 is widely expressed on leukocytes, but  blocking CXCR4 only decreased B 
cells but not T cells homing to lymph nodes (Figure 4.27,Figure 4.28), which is 
consistent with a previous study (Okada et al. 2002), possibly because T cell migration 
in lymph nodes are more CCR7 dependent (Druzd et al. 2017).  
The homing process of leukocytes to the spleen is complex, since the spleen consists 
of white pulp and red pulp. The recruitment process to red pulp is supposed to be 
passive (Nolte et al. 2002), which means that if the donor cells are blocked from 
recruitment into other organs, the circulating donor cells increase (as we observed in 
blood), which would also increase the cells in the red pulp. Therefore, the blocking 
effect in the while pulp may be masked by the increased cell number in the red pulp 
which contain a lot of blood. If an effect of decreased leukocyte subsets in total spleen 
was found, we presume this effect to be due to decreased homing to white pulp. Similar 
to the finding in the lymph node, anti-L-selectin antibody could inhibit all leukocyte 
subsets we investigated from migrating into spleen, which is contradictory to a previous 
study which found L-selectin not to be required for entering the white pulp (Nolte et al. 
2002), and another study found L-selectin-/- lymphocytes numbers were not decreased 
in spleen compared with wild type donor cells after adoptive transfer (Tang et al. 1998). 
The possible explanation is that we used different donor cells and performed 
experiment in the evening. The previous experiments all used donor cells harvested 
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from secondary lymphoid organs, while we used a mixture of spleen and bone marrow 
cells. A previous study showed blocking VLA-4 had no effects of spleen lymphocytes 
homing to the spleen white pulp, because the contribution of VLA-4 is fully redundant 
to LFA-1, whereas LFA-1 is just partly redundant to VLA-4. However, the total 
transferred lymphocyte number in the spleen was not affected (Lo, Lu, and Cyster 
2003). Our experiment did not distinguish the transferred cells in white pulp and red 
pulp, however, we could still see a blocking effect for B cells after CD11a blockade, for 
CD4 T cells after VLA-4 blockade in the evening time point. ICAM-1 is highly expressed 
at the marginal sinus where lymphocytes enter the white pulp (Nolte et al. 2002). B cell 
recruitment was LFA-1/ICAM-1 dependent. Inflammatory monocytes (Ly6Chigh) 
migration was also blocked by an anti-ICAM-1 antibody, but not anti-LFA-1 antibody 
(Figure 4.29,Figure 4.30). 
In the bone marrow, both ICAM-1 and VCAM-1 are expressed on the endothelium and 
are involved in the migration of leukocytes (Itkin et al. 2016). Anti-ICAM-1 antibody 
could target neutrophils, CD8 T cells and B cells, but this effect was not seen by 
blocking LFA-1. Blocking VLA-4 and VCAM-1 can affect B cells, CD4 T cells and CD8 
T cells, suggesting B cells and T cells (Mazo et al. 2005) migrated to bone marrow by 
interaction of VLA-4/VCAM-1. Decreased neutrophil numbers after L-selectin blockade 
indicates that neutrophil migration to bone marrow was mediated by L-selectin, while 
more CD4 T cells accumulated in bone marrow after L-selectin blocking, probably due 
to the redistribution process of donor cells after L-selection blockade. CXCR4 
contributes greatly to the homing process to the bone marrow. Blocking CXCR4 
inhibited the homing of neutrophils, B cells and T cells. Interestingly, while the CXCR4 
antagonist decreased the recruited donor cells in the tissue of bone marrow, the 
numbers of adherent donor cells actually increased, suggesting that CXCR4 
antagonist specifically blocked the transmigration process (Figure 4.31,Figure 4.32).  
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5.4. Rhythmic homing is under the control of the 
circadian clock 
 
Various studies have shown that circadian genes are expressed in leukocytes, 
including eosinophils (Baumann et al. 2013), mononuclear cells (Boivin et al. 2003), 
macrophages (Keller et al. 2009), NK cells (Logan, Arjona, and Sarkar 2011), 
neutrophils (Ella, Csepanyi-Komi, and Kaldi 2016) as well as T cells (Bollinger et al. 
2011; Druzd et al. 2017) Our data demonstrated that the expression of some circadian 
genes was oscillatory in isolated neutrophils, monocytes and B cells (Figure 4.34). 
Some studies have revealed the rhythmic expression of pro-migratory molecules is 
driven by circadian genes (Scheiermann et al. 2012; Druzd et al. 2017; Nguyen et al. 
2013). Our findings confirm that circadian genes can control the rhythmic expression 
of these molecules and drive the rhythmic recruitment process to specific places at 
specific times for many leukocyte subsets.  
In our homing experiments, more ZT13 donor cells migrated to spleen than ZT1 donor 
cells for neutrophils and B cells. However, using donor cells from Lyz2-cre Bmal1 
knockout mice, where the most important circadian gene Bmal1 (or Arntl) was deleted 
from neutrophils, monocytes and other myeloid cells, we found that the recruitment 
rhythmicity in spleen was abolished specifically in neutrophils (Figure 4.36). Using the 
CD19-cre Bmal1flox/flox mice as donor mice, where the circadian gene Bmal1 was 
knocked out specifically in B cells, Bmal1 null donor B cells failed to show increased 
homing to the spleen (Figure 4.36). In addition, compared with wild type B cells, the 
Bmal1 knockout B cells showed lower expression levels of VLA-4 and CXCR5 (Figure 
4.37), both critical molecules for B cell homing, Bmal1 knockout neutrophils showed 
lower expression of PSGL-1,  suggesting that the expression of pro-migratory 
molecules are controlled by circadian genes, and thereby influence the rhythmic 
recruitment capacity. 
On the other hand, by using Cdh5-cre/ERT2 Bmal1flox/flox mice as recipients, where the 
circadian gene Bmal1 was knocked out specifically in endothelial cells, the recruitment 
rhythmicity was abolished for all leukocyte subsets (Figure 4.39), suggesting that the 
endothelial cell circadian clock can control the rhythmic recruitment process.  
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5.5. The pathway from SCN to leukocytes 
 
Together, we have described here that the circadian clock is crucial for the recruitment 
rhythmicity of leukocytes. As described in the introduction, circadian rhythms are 
controlled at multiple levels. Since similar circadian rhythms were found in all leukocyte 
subsets, therefore, they definitely need to be synchronized by the SCN.  
One important pathway to transfer a synchronization signal from the SCN is via a 
humoral pathway. In humans, CD4 T cell numbers decline 40% during the early 
morning when cortisol levels rise (Dimitrov et al. 2009). This decline was hindered by 
the glucocorticoid receptor (GR) antagonist mifepristone, suggesting that 
glucocorticoids induced the T cell number drop in the morning. Endogenous cortisol 
activates GR and up-regulates CXCR4 expression in the morning, which will affect T 
cells homing to lymph node resulting in a redistribution of CD4 T cells (Dimitrov et al. 
2009; Okutsu et al. 2005).  
Another important hormone is epinephrine. Increased epinephrine levels in human 
plasma at the beginning of the activity phase can cause an increase in effector CD8+ 
T cells which have higher level of β-adrenergic receptors (β-AR), and therefore, are 
more sensitive to epinephrine signals (Dimitrov et al. 2009). Epinephrine can induce 
higher CX3CR1 expression, reduce the adhesive properties of effector CD8+ T cells 
and therefore recruit more cells from the marginal pool to the circulation and cause an 
increase in the morning of effector CD8+ T cells (Dimitrov et al. 2009). 
In addition to hormones, another way to transfer the central synchronizing signal is by 
local neural innervation. Neural input from β2-adrenergic receptors (β2-AR) can reduce 
the egress of lymphocytes from lymph nodes, and increase the lymphocytes number 
at night in this tissue in mice (Suzuki et al. 2016). Another study found that abolishing 
Bmal1 could abolish rhythmic expression of S1pr1 in T cells and thus inhibit the egress 
of leukocytes (Druzd et al. 2017). Together, the humoral pathways and local 
sympathetic tone likely collaborate with the intrinsic clock to control the timed 
expression of pro-migratory molecules, and therefore govern the rhythmicity of 
leukocyte migration. 
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5.6. Human blood oscillation 
 
Human blood number was known to present inverse oscillation pattern to mice likely 
because humans are diurnal and not nocturnal as mice (Born et al. 1997). Our data 
expand the knowledge of human blood oscillation pattern by investigating multiple 
leukocyte subset at several time points in combination with the expression levels of the 
key pro-migratory molecule CXCR4. We showed that different human blood leukocyte 
subsets numbers displayed the same oscillation pattern with a trough at 11am and a 
peak at 7pm (Figure 4.40). In line with another study (Zhao et al. 2017), we found that 
CXCR4 expression levels oscillated in antiphase to leukocyte numbers both in humans 
and mice. For human blood leukocyte subsets, CXCR4 expression levels increased in 
the day time when lower leukocyte numbers occurred, and decreased during the night 
when leukocyte number began to increase (Figure 4.41), suggesting that time-
dependent expression of pro-migratory molecule could drive the recruitment process 
of human blood cells. 
 
5.7. Outlook 
 
Oscillations in human and murine leukocytes have been known (Born et al. 1997; 
Ohkura et al. 2007), but no study has comprehensively investigated the migration 
properties of multiple leukocyte subsets over the course of the day. Our study clarified 
the circadian rhythms for major leukocyte subsets in blood for mice and humans and 
proved that the circadian rhythms of blood cells is at least in part due to rhythmic 
homing, which is governed by the interactions of pro-migratory molecules on 
endothelial cells and leukocytes.  
With our big screening experiments, we found that the expression of many pro-
migratory molecules is time-dependent. Most of these proved to be of importance in 
the rhythmic leukocyte recruitment process. Our study shows that the circadian gene 
Bmal1 controls rhythmic leukocyte trafficking in a cell-autonomous and tissue-specific 
manner. Together, a different combination of pro-migratory molecules guides 
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leukocyte migration to distinct organs at specific times. This time-dependent 
expression feature gives us the opportunity to find the best time for treatment. 
Therefore, future research should focus on time-of-day to improve the efficacy of drugs, 
specifically targeting leukocytes and their migration behavior.  
Besides circadian genes, the relaying signal from the central clock is also crucial for 
rhythmic migration. There is evidence that hormones could be the link between 
leukocytes and rhythmic expression of pro-migratory molecules (Gibbs et al. 2014; 
Dimitrov et al. 2009). Some key adhesion molecules, such as CXCR4, CD49d, CD11a, 
VCAM-1 and ICAM-1, were found to be rhythmically expressed in our study. The 
mechanisms of how their expression profiles are regulated by the central clock was 
largely unknown. This study provides the basis for future investigations into the shape 
of the signal transmission route from the central clock to peripheral tissues and 
leukocytes.   
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